<SEC-DOCUMENT>0001193125-15-334070.txt : 20150930
<SEC-HEADER>0001193125-15-334070.hdr.sgml : 20150930
<ACCEPTANCE-DATETIME>20150930171407
ACCESSION NUMBER:		0001193125-15-334070
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20151203
FILED AS OF DATE:		20150930
DATE AS OF CHANGE:		20150930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			pSivida Corp.
		CENTRAL INDEX KEY:			0001314102
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				262774444
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51122
		FILM NUMBER:		151134545

	BUSINESS ADDRESS:	
		STREET 1:		480 PLEASANT STREET
		STREET 2:		SUITE B300
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-926-5000

	MAIL ADDRESS:	
		STREET 1:		480 PLEASANT STREET
		STREET 2:		SUITE B300
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	pSivida LTD
		DATE OF NAME CHANGE:	20050111
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>d52141dpre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<HTML><HEAD>
<TITLE>PRE 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="4"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>WASHINGTON, DC 20549 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>(RULE 14a-101) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>SCHEDULE 14A INFORMATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp; )
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed by the Registrant
<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a Party other than the
Registrant <FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Confidential, for use of the Commission Only&nbsp;(as permitted by Rule 14a-6(e)(2))</B>. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material Pursuant to &#167;240.14a-12. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>pSivida Corp. </B></FONT></P> <P STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1">(Name of Registrant as Specified in its Charter) </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">(Name of Person(s) Filing Proxy
Statement, if Other Than the Registrant) </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate box): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;margin-left:4%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;margin-left:4%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and
state how it was determined): </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;margin-left:4%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;margin-left:4%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;margin-left:4%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount Previously Paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;margin-left:4%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;margin-left:4%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing Party: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;margin-left:4%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date Filed: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;margin-left:4%;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g52141g67j48.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">480 Pleasant Street </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Watertown, MA 02472 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">United States </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">October&nbsp;26, 2015 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dear Fellow
Stockholders, </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">It is our pleasure to invite you to this year&#146;s Annual Meeting, which will be held on
December&nbsp;3,&nbsp;2015 at 10:00 a.m. (US EST), at the Renaissance Boston Waterfront Hotel, 606 Congress Street, Boston, Massachusetts&nbsp;02210. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The proxy statement accompanying this letter describes the business that we will consider at the meeting and provides voting instructions. Your vote is important. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We hope that you are able to attend this year&#146;s Annual Meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Yours sincerely, </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR>
<TD VALIGN="bottom">


<IMG SRC="g52141mazzo.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">


<IMG SRC="g52141g86w55.jpg" ALT="LOGO">
</TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;David&nbsp;J. Mazzo</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr. Paul Ashton</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chairman</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g52141g67j48.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>December&nbsp;3, 2015 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Date:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thursday, December&nbsp;3, 2015 (Boston, Massachusetts)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Time:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">10:00 a.m. (US EST)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Place:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Renaissance Boston Waterfront Hotel, 606 Congress Street, Boston, Massachusetts&nbsp;02210</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Purpose of the Meeting </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The purpose of the meeting is to consider and act upon the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">election of six directors </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approval of stock option grant to the chief executive officer </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approval of stock option grants to the non-executive directors </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">advisory vote on executive compensation (the &#147;say-on-pay&#148; vote) </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">ratification of appointment of the independent registered public accounting firm </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any other business properly brought before the meeting </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Who May Vote at the Meeting </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders of record at the close of
business on October&nbsp;14,&nbsp;2015 (US&nbsp;EDT) are entitled to notice of, and to vote at, the 2015&nbsp;Annual Meeting of Stockholders and any adjournments. A list of stockholders as of the record date will be available for stockholder
inspection at the Annual Meeting of Stockholders and at our executive offices during normal business hours from November&nbsp;18, 2015 to the date of the 2015&nbsp;Annual Meeting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Holders of record of CHESS Depositary Interests at the close of business on October&nbsp;14,&nbsp;2015 (US&nbsp;EDT) also are entitled to
notice of the 2015&nbsp;Annual Meeting of Stockholders and any adjournments. Such holders may instruct CHESS Depositary Nominees Pty Limited, the record holder of the common stock underlying the CHESS Depositary Interests, to vote on their behalf in
accordance with the voting procedures set forth in the proxy statement. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%">


<IMG SRC="g52141g45p01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lori Freedman </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Secretary </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">October&nbsp;26, 2015 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Watertown, Massachusetts </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="96%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_1">PROXY STATEMENT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_2">VOTING INSTRUCTIONS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_3">PROPOSAL 1: ELECTION OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_4">BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_5">CORPORATE GOVERNANCE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_6">EXECUTIVE COMPENSATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_7">PROPOSAL 2: APPROVAL OF OPTION GRANT TO CEO</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_8">PROPOSAL 3: APPROVAL OF OPTION GRANTS TO THE NON-EXECUTIVE DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_9">PROPOSAL 4: ADVISORY VOTE ON EXECUTIVE COMPENSATION (THE &#147;SAY-ON-PAY&#148; VOTE)</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_10">PROPOSAL 5: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_11">INFORMATION ABOUT STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_12">ADDITIONAL INFORMATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc52141_13">DIRECTIONS TO ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_1"></A>PROXY STATEMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors of pSivida Corp. is soliciting your proxy for the 2015&nbsp;Annual Meeting of Stockholders, or Annual Meeting.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The record date for the Annual Meeting is October&nbsp;14,&nbsp;2015 (US EDT). Each stockholder of record at the close of
business on the record date is entitled to notice of, and to vote at, the Annual Meeting and any adjournments. Each of the 29,417,365 shares of common stock outstanding on the record date is entitled to one vote. The presence in person or by proxy
of one third of the shares of common stock outstanding is required for a quorum for the meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each holder of record of
CHESS Depositary Interests (CDIs) at the close of business on the record date also is entitled to notice of the Annual Meeting and any adjournments, and may instruct CHESS Depositary Nominees Pty Limited (CDN), the record holder of the common stock
underlying our CDIs, to vote on its behalf by following the instructions set forth below. Each CDI represents one share of our common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">This proxy statement and the accompanying proxy card were first mailed to stockholders on or about the date of the notice of meeting. Throughout this proxy statement, references to &#147;$&#148; are to
U.S. dollars and references to &#147;we&#148;, &#147;pSivida&#148; and the &#147;Company&#148; refer to pSivida Corp. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting to be Held on December&nbsp;3, 2015: This proxy
statement and the Annual Report for our fiscal year ended June&nbsp;30,&nbsp;2015 are available on the following websites: <U>www.edocumentview.com/PSDV</U> for street holders and <U>www.envisionreports.com/PSDV</U> for registered holders.
</B></FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_2"></A>VOTING INSTRUCTIONS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Voting Process for Stockholders </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders may vote their shares by
proxy in any of the following three ways: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Internet: You may vote by Internet 24 hours a day through 1:00 a.m., December&nbsp;3,&nbsp;2015 (US&nbsp;EST) by following the instructions that are
included on your enclosed proxy card. If you vote by Internet, you do not need to return your proxy card. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Telephone: You may vote by telephone 24 hours a day through 1:00 a.m., December&nbsp;3,&nbsp;2015 (US&nbsp;EST) by following the instructions that
are included on your enclosed proxy card. If you vote by telephone, you do not need to return your proxy card. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Mail: You may vote by signing and returning the enclosed proxy card as indicated. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may revoke your proxy at any time before it is voted by properly executing and delivering a later-dated proxy card, by later voting
by Internet or telephone, by delivering a written revocation to the Company Secretary or by attending the Annual Meeting, requesting a return of your proxy and voting in person. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although we encourage stockholders to vote by Internet, telephone or mail, whether or not they attend the Annual Meeting, stockholders
also may vote by attending, and voting in person at, the Annual Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting Process for CDI Holders </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">CDI holders may vote the shares underlying their CDIs only by their written instructions to CDN. CDI holders should complete, sign and
return the CDI Voting Instruction Form. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Computershare will collect and process voting instructions from CDI holders.
Computershare must receive the CDI Voting Instruction Form, completed and returned in accordance with the instructions provided on the form, by no later than 1:00 p.m. December&nbsp;1, 2015 (AWST). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A CDI holder may revoke a CDI Voting Instruction Form by delivering to Computershare, no
later than 1:00 p.m. December&nbsp;1, 2015 (AWST), a new CDI Voting Instruction Form or a written notice of revocation, in either case bearing a later date than the CDI Voting Instruction Form previously sent. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">CDI holders may attend the Annual Meeting, but cannot vote in person at the Annual Meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_3"></A>PROPOSAL 1: ELECTION OF DIRECTORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The individuals listed below have been nominated and are standing for election at the Annual Meeting. Each nominee, if elected, will hold
office until our 2016&nbsp;Annual Meeting and his successor is duly elected and qualified, or until he sooner dies, resigns, is removed or becomes disqualified. Each nominee is a current director elected by our stockholders. We do not anticipate
that any nominee will become unavailable to serve. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board recommends that you vote FOR the election of each of the
nominees as directors. </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>David J. Mazzo, 58 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Director since 2005, Chairman of the Board, Chairman of the Compensation Committee and member of the Science Committee </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">David J. Mazzo has been the Chief Executive Officer and a director of Caladrius Biosciences, Inc., a NASDAQ-listed company, since January 2015. Caladrius is a cell and immunotherapy development company
with an operating subsidiary providing cell process development, optimization, automation and manufacturing to the cell therapy industry. Prior to joining Caladrius, Dr.&nbsp;Mazzo served from August 2008 to October 2014 as Chief Executive Officer
and as a member of the board of directors of Regado Biosciences, Inc., a NASDAQ-listed biopharmaceutical company focused on the development of novel antithrombotic drug systems for acute and sub-acute cardiovascular indications. Prior to his leading
Regado, from March 2007 to April 2008, Dr.&nbsp;Mazzo was President, Chief Executive Officer and a director of &AElig;terna Zentaris, Inc., a publicly held international biopharmaceutical company. From 2003 until 2007, Dr.&nbsp;Mazzo served as
President, Chief Executive Officer and a director of Chugai Pharma USA, LLC, a biopharmaceutical company which was the U.S. subsidiary of Chugai Pharmaceutical Co., Ltd. of Japan. Dr.&nbsp;Mazzo has also held senior management and executive
positions in research and development and was a director of the Essex Chimie European subsidiary at Schering-Plough Corporation, a publicly held pharmaceutical company that was subsequently acquired by Merck&nbsp;&amp; Co., Inc.; Hoechst Marion
Roussel, Inc., the US subsidiary of Hoechst AG, which was subsequently acquired by Sanofi, a multinational pharmaceuticals company; and Rhone-Poulenc Rorer, Inc., a subsidiary of Rhone-Poulene SA, a French pharmaceuticals company, which was
subsequently acquired by Hoechst AG. He also previously served on the Board of Avanir Pharmaceuticals, Inc., a specialty pharmaceutical company which was sold to Otsuka Holdings in 2015. Dr.&nbsp;Mazzo earned a B.A. in the Honors Program
(Interdisciplinary Humanities) and a B.S. in Chemistry from Villanova University. In addition, Dr.&nbsp;Mazzo received his M.S. in chemistry and his Ph.D. degree in analytical chemistry from the University of Massachusetts, Amherst. He was also a
research fellow at the Ecole Polytechnique Federale de Lausanne, Switzerland. Dr.&nbsp;Mazzo&#146;s extensive experience as an executive officer and director in the life sciences industry, his understanding of the strategic and regulatory
environment in which pSivida conducts its business, his lengthy track record in global product development, his PhD in analytical chemistry and his broad scientific and managerial background provide him expertise in the oversight of companies in
this sector and the ability to guide such companies through varying operating climates. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Paul Ashton, 54 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director since 2005, President&nbsp;and Chief Executive Officer </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Ashton has been our President and Chief Executive Officer since January 2009, our Managing Director from January&nbsp;2007 to January&nbsp;2009 and our Executive Director of Strategy from
December&nbsp;2005 to January&nbsp;2007. From 1996 until its acquisition by pSivida in December&nbsp;2005, Dr.&nbsp;Ashton was the President and Chief Executive Officer of Control Delivery Systems, Inc. (CDS), a drug delivery company that he
co-founded in 1991 and that developed our Durasert&#153; technology system. Dr.&nbsp;Ashton previously was a joint faculty member in the Departments of Ophthalmology and Surgery at the University of Kentucky, served on the faculty of Tufts
University and worked as a pharmaceutical scientist at Hoffman-La-Roche. Dr.&nbsp;Ashton&#146;s long history of leadership and strategic oversight of pSivida and CDS, his role in developing and extensive knowledge of our
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
core technology platforms, products and product candidates, his scientific expertise including his PhD in pharmaceutics and strong knowledge of research and development uniquely position him to
lead pSivida in the execution of its long-term strategy. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Michael Rogers, 55 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Director since 2005, Chairman of the Audit and Compliance Committee and member of the Compensation Committee and the Governance and Nominating Committee </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Rogers has been the Chief Financial Officer of Acorda Therapeutics, Inc., a biotechnology company focused on neurological disorders, since
October 2013. From June 2009 to October 2012, Mr.&nbsp;Rogers served as Executive Vice President and Chief Financial Officer of BG Medicine, Inc., a company focused on the development and commercialization of novel biomarker-based diagnostics.
Mr.&nbsp;Rogers was Executive Vice President, Chief Financial Officer and Treasurer of Indevus Pharmaceuticals Inc., a specialty pharmaceutical company, from February&nbsp;1999 until April 2009. Mr.&nbsp;Rogers was previously Executive Vice
President and Chief Financial and Corporate Development Officer at Advanced Health Corporation, a health care information technology company, Vice President, Chief Financial Officer and Treasurer of AutoImmune, Inc., a biopharmaceutical company, and
Vice President, Investment Banking at Lehman Brothers, Inc. and at PaineWebber, Inc. During the past five years, Mr.&nbsp;Rogers was a director of Coronado Biosciences, Inc. Mr.&nbsp;Rogers&#146; significant experience as CFO of various companies
and as an investment banker have provided him with expertise in strategic transactions, corporate operations, financial management, taxes, accounting, controls, finance and financial reporting in the life sciences industry as well as valuable
insight into the strategy of pSivida. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Peter G. Savas, 67 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Director since 2008, Chairman of the Governance and Nominating Committee and member of the Audit and Compliance Committee </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Savas is Chairman and Chief Executive Officer of Alseres Pharmaceuticals, Inc., a company focused on the development of diagnostic and therapeutic products for disorders in the central nervous
system, a position that he has held since September&nbsp;2004. Mr.&nbsp;Savas has also been the Executive Chairman of Alseres Neurodiagnostics, Inc, a wholly owned subsidiary of Alseres, since July 2012, a strategic partner of SV Life Sciences Funds
III, IV and V since 2003 and an associate partner in Targeted Technologies Fund II since August 2013. From September 2013 to May 2014, Mr.&nbsp;Savas served as Chief Executive Officer of StemBioSys, a stem cell therapeutics company. From
September&nbsp;2000 to March&nbsp;2004, Mr.&nbsp;Savas served as Chief Executive Officer and President and, from April&nbsp;2001 to March&nbsp;2004, as Chairman, of Aderis Pharmaceuticals, Inc., a biopharmaceuticals company. From&nbsp;1992 to 2000,
Mr.&nbsp;Savas served as President of Unisyn, Inc., a contract manufacturer of biologics, and as Chief Executive Officer from 1995 to 2000. Mr.&nbsp;Savas is the Managing Partner of Tughill Partners, a life sciences consulting firm, and serves on
advisory boards for Children&#146;s Hospital Boston and Syracuse University. During the past 5 years, Mr.&nbsp;Savas was a director of Regenesis Biosciences. Mr.&nbsp;Savas&#146; significant experience leading life sciences companies focused on the
development of new products brings valuable insight to the strategy, operations and management of pSivida. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Douglas Godshall, 50
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director since 2012, member of the Compensation Committee, Governance and Nominating Committee and Chairman of the Science Committee
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Godshall has been the Chief Executive Officer of HeartWare International, Inc. and its predecessor HeartWare Limited, a medical
device company focused on heart failure, since September&nbsp;2006 and a director since October 2006. Prior to joining HeartWare Limited, Mr.&nbsp;Godshall served in various executive and managerial positions at Boston Scientific Corporation, where
he had been employed since 1990, including as a member of Boston Scientific&#146;s Operating Committee. From January&nbsp;2005 he served as President, Vascular </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Surgery, and for the prior five years as Vice President, Business Development, focused on acquisition strategies for the cardiology, electrophysiology, neuroradiology and vascular surgery
divisions. Mr.&nbsp;Godshall has a Bachelor of Arts in Business from Lafayette College and Masters of Business Administration from Northeastern University. Mr.&nbsp;Godshall currently serves on the board of directors of Vital Therapies, Inc., a
public company traded on the NASDAQ Stock Market that develops cell based therapies for the treatment of liver disease, since May 2013 and the Board of Directors of the Medical Device Manufacturers Association, a national trade association, since
May 2014. Mr.&nbsp;Godshall&#146;s current CEO position and prior managerial experience at public, life sciences companies provide him insights as a successful life sciences entrepreneur with in-depth knowledge of medical product strategy and
development. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>James Barry, 56 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director since 2014, member of the Audit and Compliance Committee and Science Committee </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Barry has been the Executive Vice President and Chief Operating Officer of InspireMD, a global medical device company focused on the development and commercialization of cardiovascular products,
since July 2014 and has served on the Board of Directors since 2011. Dr.&nbsp;Barry has also been a Principal at Convergent Biomedical Group since September 2010. Prior to joining InspireMD, Dr.&nbsp;Barry served as President and CEO and was a
director of Arsenal Medical from August 2011 until December 2013. Dr.&nbsp;Barry served in various executive and managerial positions at Boston Scientific Corporation, where he had been employed from 1992 until 2010, including as a member of Boston
Scientific&#146;s Operating Committee. From 2007 through 2010 he served as Senior Vice President, Corporate Technology Development, responsible for the global research and development function, and for the prior six years as Vice President,
Corporate Research and Advanced Technology Development. Dr.&nbsp;Barry is also a director of AgNovos Healthcare LLC and Cardiac Implants and in the past also served as a director of MicroChips Corporation. Dr.&nbsp;Barry has a Bachelor of Arts in
Chemistry from St. Anselm College and a Ph.D. in Biochemistry from the University of Massachusetts. Dr.&nbsp;Barry&#146;s significant experience developing products, leading research and development teams and building successful businesses coupled
with his expertise in advising clients in the pharmaceutical, biotechnology and medical device industries, brings valuable technical expertise and commercial experience to pSivida.</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_4"></A>BOARD OF DIRECTORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Committees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Board has four standing committees: the Audit and Compliance Committee, the Compensation Committee, the Governance and Nominating Committee and the Science Committee. Each standing committee is comprised entirely of independent directors, and each
standing committee has a written charter. While each committee has designated responsibilities, the committees act on behalf of the entire Board and regularly report on their activities to the entire Board. Details concerning the role and structure
of the Board and each Board committee are contained in the Corporate Governance Guidelines and the committee charters, available on the &#147;Investor&#148; section of our website at www.psivida.com under &#147;Corporate Governance&#148;.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Audit and Compliance Committee </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Audit and Compliance Committee is responsible for appointing the independent registered public accounting firm and for assisting the Board in oversight of the Company&#146;s financial reporting,
audit, legal and regulatory compliance processes. More specifically, the Audit and Compliance Committee&#146;s responsibilities include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">appointing, overseeing and, if necessary, replacing the independent registered public accounting firm, including evaluating the effectiveness and
independence of the firm at least annually, approving or pre-approving all audit and non-audit services provided by the firm and establishing hiring policies for employees or former employees of the firm, and also including resolving any
disagreements between management and the firm regarding financial reporting; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing with the independent registered public accounting firm the scope of, plans for and any difficulties with audits, and the adequacy of staffing
and compensation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing with the independent registered public accounting firm matters required to be communicated to audit committees in accordance with PCAOB AU
Section&nbsp;380, Communications With Audit Committees, as amended; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing with management and the independent registered public accounting firm the Company&#146;s internal controls, financial and critical accounting
policies (including effects of alternate GAAP methods and off-balance sheet structures, if any), risk assessment and management policies; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing with management and the independent registered public accounting firm the Company&#146;s annual and quarterly financial statements and
financial disclosure, and preparing the Audit and Compliance Committee report for inclusion in the Company&#146;s annual proxy statement; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing, or establishing standards for, the substance and presentation of information included in earnings press releases and other earnings
guidance; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing material pending legal proceedings and other contingent liabilities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">implementing an appropriate control process for reviewing and approving the Company&#146;s internal transactions and accounting;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishing procedures for receipt, retention and treatment of complaints, including the confidential and anonymous submission of concerns by
employees regarding accounting, internal accounting controls or auditing matters; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">receiving from management a report of any significant deficiencies and material weaknesses in the design or operation of the Company&#146;s internal
controls, and any fraud involving management or other employees who have a significant role in the Company&#146;s internal controls; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">presenting to the Board annually an evaluation of the Audit and Compliance Committee&#146;s performance and charter; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">performing such other activities as the Board or the Audit and Compliance Committee deem appropriate. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The members of the Audit and Compliance Committee are Mr.&nbsp;Rogers (chair),
Mr.&nbsp;Savas and Dr.&nbsp;Barry. Mr.&nbsp;Rogers and Mr.&nbsp;Savas have each been a member of the Audit and Compliance Committee for the entirety of fiscal 2015 and Dr.&nbsp;Barry has served on the Committee since December&nbsp;11, 2014,
replacing Mr.&nbsp;Godshall who served on the Committee during fiscal 2015 until December&nbsp;11, 2014. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board has
determined that all current and fiscal 2015 members of the Audit and Compliance Committee are independent for purposes of service on the Audit and Compliance Committee as provided in the rules of the Securities and Exchange Commission (SEC), The
NASDAQ Stock Exchange (NASDAQ) and the Australian Securities Exchange (ASX). The Board also has determined that Mr.&nbsp;Rogers and Mr.&nbsp;Savas are audit committee financial experts. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit and Compliance Committee met five times during the fiscal year ended June&nbsp;30,&nbsp;2015. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation Committee </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee is responsible for discharging the Board&#146;s responsibilities relating to executive compensation and
overseeing our compensation and employee benefits plans and practices. More specifically, the Compensation Committee&#146;s responsibilities include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">developing and periodically reviewing compensation policies and practices applicable to executive officers; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">determining and approving the compensation of the CEO and other executive officers; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">supervising, administering and evaluating incentive, equity-based and other compensatory plans of the Company in which executive officers and key
employees participate, including approving guidelines and size of grants and awards, making grants and awards, interpreting and promulgating rules relating to the plans, modifying or canceling grants or awards, designating employees eligible to
participate and imposing limitations and conditions on grants or awards; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing and approving, subject to stockholder approval as required by any applicable law, regulation or NASDAQ rule, the creation or amendment of any
incentive, equity-based and other compensatory plans of the Company in which executive officers and key employees participate (other than amendments to tax-qualified employee benefit plans and trusts, and any supplemental plans thereunder, that do
not substantially alter the costs of such plans to the Company or are to conform such plans to applicable laws or regulations) and all related policies and programs; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing and approving any employment agreements, severance arrangements, change-in-control arrangements or special or supplemental employee benefits,
and any material amendments to any of the foregoing, applicable to executive officers and other employees of the Company; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">making individual determinations and granting any shares, stock options or other equity-based awards under all equity-based compensation plans that are
outside approved guidelines for such grants, and exercising such power and authority as may be required or permitted under such plans; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annually evaluating the performance of the Compensation Committee; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annually reviewing and reassessing the charter of the Compensation Committee and, if appropriate, recommending changes to the Board;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annually evaluating the adequacy of directors&#146; compensation and the composition of such compensation; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing the Compensation Discussion&nbsp;&amp; Analysis to be included in the Company&#146;s annual proxy statement or Annual Report on Form 10-K and
issuing a Compensation Committee report thereon as required by the SEC to be included in the Company&#146;s annual proxy statement or Annual Report on Form 10-K filed with the SEC; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing significant risks or exposures facing the Company and discussing the relationship, if any, between these risks and the Company&#146;s
compensation policies and practices, as well as appropriate means through compensation policy to mitigate these risks; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">performing such other duties and responsibilities as may be assigned to the Compensation Committee by the Board or as designated in plan documents; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">forming and delegating authority to subcommittees, comprised of one or more members of the Compensation Committee, when the Compensation Committee
deems appropriate. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The members of the Compensation Committee are Dr.&nbsp;Mazzo (chair), Mr.&nbsp;Rogers
and Mr.&nbsp;Godshall, each of whom was a member of the Compensation Committee for the entirety of fiscal 2015. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee met six times during the fiscal year ended June&nbsp;30,&nbsp;2015. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Governance and Nominating Committee
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Governance and Nominating Committee is responsible for identifying and recommending to the Board individuals qualified
to serve as directors, advising the Board with respect to the Board composition and procedures, overseeing the evaluation of the Board and overseeing our corporate governance. The Governance and Nominating Committee has periodically engaged third
parties to identify and evaluate candidates qualified to serve as directors of the Company and may continue to do so in the future. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The members of the Governance and Nominating Committee are Mr.&nbsp;Savas (chair), Mr.&nbsp;Rogers and Mr.&nbsp;Godshall, each of whom was a member of the Governance and Nominating Committee for the
entirety of fiscal 2015. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Governance and Nominating Committee met seven times during the fiscal year ended
June&nbsp;30,&nbsp;2015. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Science Committee </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Science Committee is responsible for reviewing the science, clinical and regulatory strategy underlying the company&#146;s research and development programs and making recommendations to the Board on
key strategic and tactical issues relating to the Company&#146;s research and development activities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The members of the
Science Committee are Mr.&nbsp;Godshall (chair), Dr.&nbsp;Mazzo and Dr.&nbsp;Barry, each of whom was a member of the Science Committee since it was formed in December 2014 through the remainder of fiscal 2015. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Science Committee met one time during the fiscal year ended June&nbsp;30,&nbsp;2015. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Attendance at Board and Committee Meetings </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors met ten times during the fiscal year ended June&nbsp;30,&nbsp;2015. Each of the directors who served during fiscal 2015 standing for election attended at least 75% of the meetings
of the Board and the committees on which he served. In accordance with our policy that encourages each director to attend Annual Meetings, each of the directors who served during fiscal 2015 standing for election also attended our 2014&nbsp;Annual
Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee Interlocks and Insider Participation </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None of our executive officers serves as a member of the Board of Directors or compensation committee, or other committee serving an
equivalent function, of any other entity that has one or more of its executive officers serving as a member of our Board of Directors or compensation committee. None of the members of our compensation committee has ever been employed by us. For a
description of transactions, if any, between us and members of our compensation committee and affiliates of such members, please see the section of this Proxy Statement titled &#147;Transactions with Related Persons.&#148; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_5"></A>CORPORATE GOVERNANCE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Director Independence </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board, based on the recommendation of the Governance and Nominating Committee, has determined that Dr.&nbsp;Mazzo, Mr.&nbsp;Godshall,
Dr.&nbsp;Barry, Mr.&nbsp;Rogers and Mr.&nbsp;Savas are independent under applicable standards of NASDAQ and ASX. Our other director, Dr.&nbsp;Ashton, serves as our President and Chief Executive Officer. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Leadership Structure </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board has chosen to separate the roles of Chairman and Chief Executive Officer and believes that such a separation of roles is in the best interests of the Company and its stockholders.
Dr.&nbsp;Mazzo&#146;s extensive qualifications to serve as a director and the perspective that he brings to the Company as an independent director are designed to provide for effective leadership for the Board and support for our executive team.
Dr.&nbsp;Ashton&#146;s long history with the Company and familiarity with its products and product candidates make him best positioned to lead us in the execution of our strategy and in the daily management of our business. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board&#146;s Role in Risk Oversight </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">It is management&#146;s responsibility to manage risk and bring to the Board&#146;s attention risks that are material to the Company. The Board has oversight responsibility for the systems established to
report and monitor the most significant risks applicable to the Company. The Board administers its risk oversight role directly and through its committee structure. The Board reviews strategic and financial risks and exposures associated with the
Company&#146;s long-term strategy, development and commercialization of products and product candidates and other matters that may present material risk to the Company&#146;s operations, strategy and prospects. The Audit and Compliance Committee
reviews risks associated with financial and accounting matters, including financial reporting, accounting, disclosure and internal control over financial reporting. The Compensation Committee reviews risks related to executive compensation and the
design of compensation programs, plans and arrangements. The Governance and Nominating Committee manages risks associated with corporate governance and Board composition and procedures. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Transactions with Related Persons </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We maintain a written &#147;Policy
Regarding Related Person Transactions&#148;. Under this policy, the Audit and Compliance Committee or, in time sensitive instances, the chair of the Audit and Compliance Committee, has responsibility for reviewing and approving or ratifying any
transaction in which we and any of our directors, director nominees, executive officers or 5% stockholders and their immediate family members are participants, or in which such persons have a direct or indirect material interest, as provided under
SEC rules. In reviewing transactions, the committee or the chair considers all of the relevant facts and circumstances, and approves only those transactions that the committee or the chair in good faith determines to be in, or not inconsistent with,
the best interests of pSivida and its stockholders. During fiscal 2015 and 2014, there were no such related-person transactions. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Communications with Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Stockholders and other interested parties may communicate directly with the Board, the independent directors, the Chairman of the Board, any other group of directors or any individual director by writing
to such group or individual at the following address: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name(s) of Director(s), Group of Directors or Board of Directors
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">c/o Company Secretary </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">pSivida Corp. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">480 Pleasant Street </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Watertown, MA 02472 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">United States </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company Secretary will forward such communications to the
relevant group or individual at or prior to the next meeting of the Board. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stockholder Nominations for Director </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Governance and Nominating Committee will consider written stockholder recommendations for candidates for the Board, which
recommendations should be delivered or mailed, postage prepaid, to: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Company Secretary </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">pSivida Corp. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">480 Pleasant Street </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Watertown, MA 02472 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">United States </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholder recommendations must include certain relevant information concerning the candidate, the stockholder making the recommendation
and any beneficial owner on whose behalf the recommendation is made. The required information is set forth in our Stockholder Nomination Policy, available on the &#147;Investor&#148; section of our website at www.psivida.com under &#147;Corporate
Governance&#148;. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Governance and Nominating Committee will evaluate candidates for director who are recommended by
stockholders on the same basis as candidates recommended by other sources. Considerations include the Governance and Nominating Committee&#146;s discretionary assessment of the skills represented and required on the Board, and an evaluation of
candidates against the standards and qualifications set forth in our Corporate Governance Guidelines and criteria approved by the Board from time to time. We do not have a formal policy with respect to diversity, although we seek to have a Board
that reflects a range of talents, ages, skills, viewpoints, professional experience, educational background, expertise, gender, race and ethnicity. The Governance and Nominating Committee will determine whether to interview any candidate in its sole
discretion. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Audit and Compliance Committee Report </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As more fully described in its charter, the Audit and Compliance Committee oversees pSivida&#146;s financial reporting process on behalf of the Board of Directors. Our management is responsible for the
Company&#146;s financial reporting process, including assuring that the Company develops and maintains adequate financial controls and procedures, and assessing compliance therewith. Our independent registered public accounting firm,
Deloitte&nbsp;&amp; Touche LLP (Deloitte), is responsible for performing an audit of the effectiveness of the Company&#146;s internal control over financial reporting in conjunction with an audit of the consolidated financial statements in
accordance with standards of the Public Company Accounting Oversight Board (United States) (PCAOB) and issuing its opinions on the financial statements and the effectiveness of internal control over financial reporting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The committee reviewed and discussed the Company&#146;s audited consolidated financial statements for the fiscal year ended June&nbsp;30,
2015 with our management and Deloitte. The committee also reviewed and discussed with Deloitte the audited financial statements and the matters required by PCAOB Auditing Standard No.&nbsp;16, <I>Communication with Audit Committees.</I> The
committee met with Deloitte, with and without management present, to discuss the results of their examinations, their evaluation of our internal controls, and the overall quality of our financial reporting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The committee discussed with Deloitte the firm&#146;s independence and received from Deloitte the written disclosures and the letter
required by PCAOB Ethics and Independence Rule 3526 (Communication with Audit Committees Concerning Independence). The committee has concluded that Deloitte&#146;s provision of audit and pre-approved non-audit services to the Company is compatible
with Deloitte&#146;s independence. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the above-referenced reviews and discussions with our management and Deloitte,
the Audit and Compliance Committee recommended to the Board of Directors that the Company&#146;s audited consolidated financial statements be included in its Annual Report on Form 10-K for the year ended June&nbsp;30, 2015, for filing with the SEC.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Submitted by </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Audit and Compliance Committee </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael Rogers </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter G. Savas </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">James Barry </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Beneficial Ownership </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The tables below set forth information regarding beneficial ownership of our shares of common stock as of September&nbsp;15, 2015 by (1)&nbsp;any person or entity who, to our knowledge, beneficially owns
5% or more of our shares of common stock based on filings with the SEC and (2)&nbsp;our directors and Named Executive Officers. Unless otherwise indicated, the address for each of the beneficial owners listed below is: c/o pSivida Corp.,
480&nbsp;Pleasant Street, Watertown, MA 02472, United States. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:59pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficial Owner</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Aggregate&nbsp;Number&nbsp;of<BR>Shares Beneficially<BR>Owned<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent&nbsp;of&nbsp;Shares<BR>Beneficially&nbsp;Owned</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5% or Greater Beneficial Owner:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Allan Gray Australia Pty Limited</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Level 2, Challis House</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">4-10 Martin Place</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sydney, Australia NSW 2000</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,320,455</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.80</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">North Run Capital, LP</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">One International Place, Suite 2401</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Boston, MA 02110</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,144,086</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.29</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pfizer, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Treasurer&#146;s Division</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">235 East 42nd Street</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">New York, NY 10017 USA</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,862,093</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.33</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Directors and Executive Officers:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David J. Mazzo</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">375,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">James Barry</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,333</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael Rogers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">270,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter G. Savas</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">230,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Douglas Godshall</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul Ashton</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,436,852</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lori Freedman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">471,398</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.58</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Leonard S. Ross</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,050</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>All current directors and executive officers as a group (8 persons)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,100,133</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.70</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">*
Represents holdings of less than 1% of our outstanding common stock </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reflects sole voting and investment power, except as indicated below. Includes shares of common stock which each of the following persons had the right to acquire on
September&nbsp;15, 2015 or within sixty (60)&nbsp;days thereafter through the exercise of options and/or warrants: Allan Gray Australia Pty Ltd (350,000), Dr.&nbsp;Mazzo (375,000), Dr.&nbsp;Barry (13,333), Mr.&nbsp;Rogers (270,000), Mr.&nbsp;Savas
(230,000), Mr.&nbsp;Godshall (120,000), Dr.&nbsp;Ashton (979,330), Ms.&nbsp;Freedman (374,975)&nbsp;and Mr.&nbsp;Ross (183,050). </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Of such shares, 16,781 are held by the trustee of the Dr.&nbsp;Ashton Children&#146;s Irrevocable Trust as to which Dr.&nbsp;Ashton disclaims beneficial ownership.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Section&nbsp;16(a) Beneficial Ownership Reporting Compliance </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;16(a) of the Exchange Act requires that our directors, officers and 10%&nbsp;beneficial owners file reports of ownership and
changes in ownership of our securities with the SEC and NASDAQ. To our knowledge, all reports were timely filed during the fiscal year ended June&nbsp;30,&nbsp;2015. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_6"></A>EXECUTIVE COMPENSATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee Report </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has reviewed the &#147;Compensation Discussion and Analysis&#148; below and discussed it with management. Based on this review and discussion, the Compensation Committee
recommended to the Board that the &#147;Compensation Discussion and Analysis&#148; as it appears below be included in this proxy statement and be incorporated by reference into the Company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year
ended June&nbsp;30,&nbsp;2015. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Submitted By </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Compensation Committee </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">David J. Mazzo </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael Rogers </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Douglas Godshall </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Discussion and Analysis </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the following compensation
discussion and analysis, we provide highlights of our performance for fiscal 2015, an overview of our compensation philosophy, program and decision-making process, including the Compensation Committee&#146;s use of consultants and peer group
information, and the material elements of compensation earned with respect to fiscal 2015 by each of our principal executive officer, our principal financial officer and our other executive officer (our &#147;Named Executive Officers&#148;). For
fiscal 2015, our Named Executive Officers were Paul Ashton, President and Chief Executive Officer, Lori Freedman, Vice President, Corporate Affairs, General Counsel and Secretary, and Leonard Ross, Vice President, Finance. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Fiscal 2015 Highlights </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In fiscal 2015, we made significant progress toward our goal of becoming the leader in sustained release drug delivery products in
ophthalmology and beyond. These highlights of our business performance and accomplishments for fiscal 2015 were considered significant by the Compensation Committee: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our lead product candidate, Medidur&#153; for posterior uveitis, continued to progress through its pivotal Phase III trials with a new drug application
(NDA) anticipated in the first half of 2017. We remain optimistic that our trials will show Medidur to be both safe and effective. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We completed enrollment of our first Phase III trial in the third quarter of fiscal 2015, and commenced enrollment of our second Phase III trial. Based
on discussions with the FDA, we plan to seek U.S. approval based on 6-month data from each trial, supplemental data from an inserter study and referenced data from the Phase III trials of ILUVIEN<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> for diabetic macular edema (DME). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our ongoing assessment of masked safety data from all patients in our first Phase III trial at the three-month follow-up visit showed only a 5%
difference in elevated intraocular pressure (IOP) over 21mmHg between study eyes (2/3&#146;s of which received Medidur) and fellow non-study eyes (none of which received Medidur). Initial IOP elevation is an indication of the likelihood of
subsequent clinically significant IOP increases so the minimal difference suggests a favorable outcome for a key safety measure of our Phase III trials. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Top-line results from an investigator-sponsored study of low and high doses of Medidur (we are studying only the low dose) showed a statistically
significant reduction in recurrence of uveitis and a statistically significant improvement in visual acuity in eyes with uveitis treated with Medidur compared to those not treated with Medidur. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our pre-clinical research program made significant progress. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect an investigational new drug application (IND) to be filed for an implant utilizing our patented Durasert&#153; technology to provide
sustained delivery of a corticosteroid directly to the knee for 6 months. The implant, which resulted from our collaboration with Hospital for Special Surgery, the leading specialty hospital for orthopedics and rheumatology, is intended to provide
long-term pain relief for severe knee osteoarthritis, delaying or eliminating the need for knee replacement surgery. We are pleased to potentially broaden the application of our technology outside the field of ophthalmology.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We made an important advance in the development of Tethadur&#153; to provide sustained delivery of proteins, antibodies and other large molecules. In
the lab, we were able to achieve two key elements for sustained delivery&#151;higher molecule loading capacity and enhanced molecule stability&#151;and are ready to proceed to confirmatory testing in pre-clinical models.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We began a new pre-clinical program to use our Durasert technology to provide sustained delivery of drug to treat age-related macular degeneration and
continued our pre-clinical research with respect to its use for other significant eye diseases. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We entered into two funded technology evaluation agreements with a leading global pharmaceutical company to evaluate the use of our Durasert technology
to deliver two different compounds to treat a significant ophthalmic disease. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">ILUVIEN<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, our
lead partnered product, advanced in both the U.S. and the EU. Providing three years of effective treatment from a single injection, ILUVIEN offers an attractive treatment alternative for DME patients. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">ILUVIEN was approved in the U.S. in the first quarter of fiscal 2015 for a broad indication: treatment of DME in patients who have been previously
treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure. We received a $25 million milestone payment as a result of the FDA approval. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our licensee Alimera Sciences launched ILUVIEN in the U.S. and completed the first quarter of U.S. commercialization with solid sales.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sales of ILUVIEN continued in the U.K, and in fiscal 2015, Alimera relaunched ILUVIEN in Germany and launched it in Portugal. ILUVIEN completed
marketing authorizations in all 17 EU countries where approval had been sought. ILUVIEN is indicated in the EU for chronic DME considered insufficiently responsive to available therapies. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We ended the year with $28.5 million in cash, our highest level of liquidity ever. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation Philosophy </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our compensation program is designed to attract, retain and motivate executive officers to achieve our business objectives and build value
for our stockholders and to reward them for that performance. Accordingly, our executive compensation program is weighted to at-risk incentive compensation earned on the basis of performance. Of the three principal elements in our program, only one,
salary, is fixed. The other two elements are variable: cash bonuses, which are earned based on the Compensation Committee&#146;s assessment of annual performance, and stock options, which deliver value only to the extent the value of our stock
increases. Our mixture of cash and equity compensation is designed to incentivize and reward our executive officers to attain short and long-term goals and to encourage retention. Compensation takes into account Company performance, individual
contribution and peer compensation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board and its Compensation Committee are responsible for our executive compensation
and seek to provide compensation to our Named Executive Officers that over time is competitive with compensation paid by comparable companies for comparable responsibilities and positions. Our goal is that each of total compensation, base salary,
total cash compensation and long-term equity incentives will generally over time achieve </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
approximately the 50th percentile for executive officers in comparable positions at our peer group companies as well as other comparable companies, with the potential to earn total cash
compensation and long term equity incentives as high as the 75th percentile for outstanding performance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board seeks to
make compensation decisions transparent to our stockholders and executives and thereby to achieve our objectives by communicating openly with our executive officers and stockholders regarding our compensation process, pay structure and performance
objectives. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation Consultant </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee retained Radford, an Aon Hewitt company, as its independent consultant to assist in evaluating our executive compensation programs and practices and to make recommendations
regarding fiscal 2015 compensation. For fiscal 2015, Radford prepared competitive market data for the compensation of our executive management team, evaluated the appropriateness of and made recommendations regarding our peer group, analyzed our
short term and long term incentive plan designs, analyzed equity retention and reviewed our equity burn rate and dilution levels relative to market, assessed our compensation practices and levels against those of our peer group companies and other
comparable companies and made recommendations regarding base salary, target bonus percentage and long term incentive compensation for each Named Executive Officer, and updated the Compensation Committee on compensation trends and regulatory
developments. None of Radford, Aon Hewitt or their affiliates provides other services to the Company. The Compensation Committee has sole responsibility for the selection, engagement, removal and compensation of its compensation consultant.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Peer Group </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The peer group selected by the Compensation Committee for fiscal 2015 was composed of 20 public, biopharmaceutical companies selected
based on a comparable business and financial profile to us, including stage of development, employee size, annual revenues and market value. The fiscal 2015 peer group included Acura Pharmaceuticals, Agenus, Alexza Pharmaceuticals, Alimera Sciences,
Anthera Pharmaceuticals, ArQule, CEL-SCI, Celsion, Cumberland Pharmaceuticals, Cytori Therapeutics, CytRx, DURECT, Hemispherx BioPharma, Heron Therapeutics, OncoGenex Pharmaceuticals, Ocothyreon, Pozen, Sunesis Pharmaceuticals, Transcept
Pharmaceuticals and Vermillion. Our peer group was recommended by Radford and approved by the Compensation Committee. The fiscal 2015 peer group did not include six companies used in the fiscal 2014 peer group: Cornerstone Therapeutics and NuPathe,
which were acquired, as well as Anika Therapeutics, AP Pharma, BioDelivery Sciences International and Zalicus, which no longer had a business or a financial profile comparable to ours. The fiscal 2015 peer group added five new comparator companies
to the fiscal 2014 peer group: ArQule, Cytori Therapeutics, Heron Therapeutics, Sunesis Pharmaceuticals and Vermillion. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Say-on-Pay
Feedback from Stockholders </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board and the Compensation Committee value the opinions of our stockholders, and consider
the outcome of the annual advisory stockholder vote when making future compensation decisions for our Named Executive Officers. At our 2014 annual meeting, 90% of the vote of stockholders present in person or represented by proxy and voting at the
meeting approved our advisory resolution regarding compensation of Named Executive Officers. With stockholders showing strong support of our executive compensation program, the Compensation Committee continued its regular practice of evaluating the
program to reflect continued linkage between pay and Company performance and carefully considered actual compensation payouts, seeking to provide compensation that follows our compensation philosophy and meets our compensation objectives described
above. In light of all pertinent considerations, the Compensation Committee believes that our compensation programs embody a pay-for-performance philosophy that is well suited for these purposes. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Overview of Compensation Program Employment Agreements </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Paul Ashton, our President and Chief Executive Officer, and Lori Freedman, our Vice President, Corporate Affairs and General Counsel, are employed under employment agreements that were negotiated on an
arm&#146;s-length </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
basis in 2006 in connection with the acquisition of Control Delivery Systems (CDS) by our then Managing Director and CEO and approved by our Board of Directors. Dr.&nbsp;Ashton&#146;s employment
agreement was amended in 2008 to reflect his promotion to Managing Director with ultimate executive authority in the management team. Both of these employment agreements provide for a minimum base salary, a discretionary annual cash bonus,
discretionary equity incentives and severance payments as described further under <I>Elements of Compensation: Termination-Based Compensation</I>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I></I>Leonard Ross, our Vice President, Finance, became our principal financial officer in March 2009. As a result of his appointment, the Company, under the direction of the Compensation Committee,
entered into an employment agreement with Mr.&nbsp;Ross that provides for a minimum base salary, a discretionary annual cash bonus, discretionary equity incentives and severance payments as described further under <I>Elements of Compensation:
Termination-Based Compensation</I>.<I> </I></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Elements of Compensation. </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our compensation program provides our executive officers with the following elements of compensation: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary </I>provides fixed annual compensation for performing day-to-day responsibilities. The Compensation Committee intends to achieve over
time base salary of approximately the 50th percentile relative to comparable positions at our peer group companies as well as other comparable companies (&#147;Market&#148;). The Compensation Committee considers individual and Company performance in
addition to comparable Market salaries in determining whether to make annual base salary adjustments. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Annual Performance Bonuses </I>are awarded by the Compensation Committee on a discretionary basis based on the Compensation Committee&#146;s
assessment of annual performance as guided by achievement of pre-established annual Company goals set by the Board. The Compensation Committee intends that salary and annual bonuses together will over time generally achieve approximately the 50th
percentile of Market for total cash compensation and in the case of exceptional Company and individual performance, up to approximately the 75th percentile of Market. Bonuses are generally payable in cash, although the Compensation Committee retains
the flexibility to pay bonuses in other forms. Bonuses are designed to reward executives for their contributions to the Company&#146;s overall performance in a given year, to encourage executives to create and protect stockholder value, and to focus
executives on short-term bonus objectives that are expected to have a positive impact on our success. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Equity Incentive Compensation </I>has historically been in the form of stock options granted annually under a plan approved by our
stockholders but the Compensation Committee may also award restricted stock or other equity incentives under the plan. The Compensation Committee intends that over time annual long-term equity compensation will generally achieve approximately the
50th percentile of Market with the potential to be at up to approximately the 75th percentile in the case of outstanding individual and Company performance. The Compensation Committee compares the long-term equity incentive value of the annual
grants to the long-term equity value of Market annual grants and the percentage that the annual grants represent of total pSivida shares outstanding compared to the percentage of Market annual grants compared to Market shares outstanding. The
Compensation Committee also considers the annual and cumulative equity plan dilution against the peer group companies to evaluate whether overall equity usage is competitive and reasonable. The Compensation Committee may also consider the amount and
monetary value of current options outstanding, the number of option grants made in prior years, Company and individual performance, percentage of outstanding capital stock represented by grants, market value of our stock and competitive and other
factors. Our long-term equity compensation awards are designed and structured to align our executive officers&#146; long-term interests with those of our stockholders. Because stock options have an exercise price equal to or greater than the share
price on the date of grant, they have value only when the value of our stock increases. Therefore, our executives only receive value as value is created for stockholders. Our options have been granted with time vesting and at annual intervals,
intended to serve as an important retention and motivation device. The Compensation Committee has also for some </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
option grants made vesting contingent on achievement of performance conditions. Typically ten-year grants, our options provide incentives for sustained long-term performance. Each award to our
CEO has been approved by our stockholders consistent with the rules of the ASX. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Insurance and Retirement Benefits</I> consist of health, dental, life and long-term disability insurance and a 401(k) plan retirement match, and are
provided to all employees. Executives do not have any benefits that are not available to other employees. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In determining target total compensation (base salary, target and maximum bonus potential and equity incentives), the Compensation
Committee takes into account past compensation, individual performance, individual responsibility, contractual obligations, compensation practices at peer group companies and in industry surveys, compensation programs for all of our employees, the
compensation of each executive relative to that of other executives and any special considerations such as recruitment, promotions, organizational changes and transitional roles, the Company&#146;s headcount, market capitalization and stage of
business development. The availability of health and welfare insurance and retirement benefits helps us maintain our competitive position in the market for executive talent but does not form part of the basis for the Compensation Committee&#146;s
determination of total compensation of executive officers for any year, since these benefits are offered to all of our employees. We do not provide special perquisites to our executives. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation Benchmarking </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In May 2014, the Compensation Committee engaged
Radford to conduct a new benchmarking study for fiscal 2015. In July 2014, following a review and analysis of our executive compensation program, Radford presented the Compensation Committee with a report and recommendations on executive
compensation for fiscal 2015. Radford&#146;s Recommendations included a market analysis of base salaries, total cash compensation and equity compensation relative to a market consensus (FY2015 Market Consensus) based on the peer group discussed
above as well as peer data derived from the published Radford Global Life Sciences Survey representing public biotechnology and pharmaceutical companies with fewer than 150 employees, weighted equally. The Compensation Committee used Radford&#146;s
recommendations as a starting point to consider market competitiveness and ultimately sets compensation after also considering individual and Company performance. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Fiscal 2015 Executive Compensation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Compensation for our Named Executive
Officers with respect to fiscal 2015 was as follows: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Fiscal 2015 Base Salary and Target Bonuses. </I>For fiscal 2015, the Compensation Committee targeted base salary and total compensation of our
executive officers around the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of FY2015
Market Consensus, but limited by a maximum increase of 3% from fiscal 2014 base salaries. Fiscal 2015 base salary was increased for our Named Executive Officers to: $463,500 for Dr.&nbsp;Ashton, 7% percent below the 50</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the FY2015 Market Consensus and an increase of 3% from
Dr.&nbsp;Ashton&#146;s fiscal 2014 base salary, $339,900 for Ms.&nbsp;Freedman, 5% percent below the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th </SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">percentile of the FY2015 Market Consensus and an increase of 3% from Ms.&nbsp;Freedman&#146;s fiscal 2014 base salary, and $247,800 for Mr.&nbsp;Ross, 2% percent above the 50</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the FY2015 Market Consensus and an increase of 3% from
Mr.&nbsp;Ross&#146; fiscal 2014 base salary. The Compensation Committee set fiscal 2015 target bonus percentages at 55% for Dr.&nbsp;Ashton, 35% for Ms.&nbsp;Freedman and 30% for Mr.&nbsp;Ross, at the 50</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the FY2015 Market Consensus, which together with
fiscal 2015 base salary, positioned total target cash compensation levels between the 25</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"> and 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
percentiles of the FY2015 Market Consensus for Dr.&nbsp;Ashton and Ms.&nbsp;Freedman and slightly above the
50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the FY2015 Market Consensus for
Mr.&nbsp;Ross. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Fiscal 2015 Annual Performance Bonus.</I> The Compensation Committee determines the discretionary annual bonuses using corporate goals for all Named
Executive Officers and individual performance assessments for each Named Executive Officer other than the CEO. Dr.&nbsp;Ashton&#146;s payout of his target </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
bonus opportunity is entirely based on the corporate performance score because the Compensation Committee believes that the CEO&#146;s payout should be based on his ability to lead the Company to
achieve its corporate goals. For each other Named Executive Officer, the weighting is 75% towards corporate goals and 25% towards individual performance. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Each corporate goal includes a minimum, target and exceeds performance level and is assigned a percentage weighting as a portion of the overall bonus potential. The fiscal 2015 corporate goals and
weightings were approved by the independent directors based on corporate goals recommended by the Compensation Committee with input from the CEO and other Named Executive Officers. The Compensation Committee intended the fiscal 2015 corporate goals
to promote the achievement of the Company&#146;s strategy and to motivate the executives to achieve high performance at the Company level. The corporate goals were set with a reasonable level of difficulty that required that our Named Executive
Officers perform at a high level in order to meet the target levels, and the likelihood of attaining even the minimum goals was not assured. The fiscal 2015 corporate performance goals covered the following areas and their respective weightings were
as follows: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Timing of completion of enrollment of the ongoing Phase III study of Medidur for posterior uveitis (25%) </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Progress of the short-duration clinical utilization study of our redesigned proprietary inserter for Medidur (25%) </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Initiation of enrollment of a clinical study for a Tethadur product and initiation of enrollment for a clinical study to evaluate an implant using the
Company&#146;s Durasert&#153; technology to treat pain associated with severe osteoarthritis of the knee (15%) </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Execution in accordance with the operating plan and budget (5%) </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount of available cash, cash equivalents and marketable securities (5%) </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Progress in advancing AMD or other degenerative ophthalmic product development and in advancing potential collaborations and licenses (25%)
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Depending on performance, each goal was eligible for a potential score on a performance scale of 0 to 5,
with a score of 0 for no achievement, 3 for achievement of the target performance and 5 for exceeding achievement. The score for each goal contributes to a weighted average score based on the above percentages. For fiscal 2015, the Board determined
that the weighted average score should generally result in a payout percentage of the target bonus amount as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:84pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighted Average Score</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Payout&nbsp;Level<BR>(%&nbsp;of&nbsp;Target&nbsp;Amount)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">110</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">These goals and weightings serve to guide the Compensation Committee in determining the amount of the
bonus. The Compensation Committee has full discretion to determine the level of performance for each goal and the amount and payment of bonuses. The Compensation Committee can also exercise its discretion to modify the performance goals at any time
during or after the year, to adjust the performance levels and weightings, and to determine the actual amounts and payout terms of the annual bonuses without regard to achievement of the goals and weightings. This discretion is communicated to the
executives. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">After the end of fiscal 2015, the Compensation Committee assessed the performance of each
corporate goal for fiscal 2015, based on its view of the general performance of each item and with input from the CEO. The Compensation Committee determined that the corporate performance was as follows: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our completion of enrollment of the first Medidur for posterior uveitis Phase III trial by March&nbsp;31, 2015 resulted in a score of 3.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">While we determined the requirements for the Medidur inserter study based on discussions with the FDA, we did not commence the study, resulting in a
score of 1. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">No clinical study was initiated during the fiscal year for either a Tethadur product or an osteoarthritis product, resulting in a score of 0.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our execution of approximately 80%, but not 100%, of our operating plan within our approved operating budget resulted in a score of 1.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our $28.5 million in cash at the end of fiscal year 2015 resulted in a score of 5. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our progress in advancing AMD ophthalmic product development and execution of two technology evaluation agreements with a leading global pharmaceutical
company resulted in a score of 3. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Using the above predetermined weightings, the weighted average score
based on the Compensation Committee&#146;s assessment of achievement of the corporate goals was 2.05 out of 5.0. Based on the above payout percentage scale, this score resulted in a corporate performance achievement of 52.5%. The Compensation
Committee determined to use the performance score and the predetermined payout percentages in the determination of bonuses. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The target payout established for Dr.&nbsp;Ashton for fiscal 2015 was 55% of annual base salary. Based on this target payout and the
52.5% performance score assigned to the corporate goals by the Compensation Committee, Dr.&nbsp;Ashton received a fiscal 2015 annual bonus of $133,836, equal to approximately 29% of his fiscal 2015 base salary. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The target payout established for Ms.&nbsp;Freedman for fiscal 2015 was 35% of annual base salary, weighted 75% towards corporate goals
and 25% towards individual performance. Ms.&nbsp;Freedman&#146;s individual performance assessment was based on her facilitatation of business objectives, coordination of intellectual property strategy to optimize product development strategies,
management of public company reporting and related Securities and Exchange Commission matters, participation in the Company&#146;s investor relations and communications functions and support of the execution of the Company&#146;s business
development strategy. The CEO recommended and the Compensation Committee approved an individual performance score of 100% for Ms.&nbsp;Freedman. Based on the corporate performance score, her individual performance score and her target payout,
Ms.&nbsp;Freedman received a fiscal 2015 annual bonus of $76,620, equal to approximately 22.5% of her fiscal 2015 base salary. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The target payout established for Mr.&nbsp;Ross for fiscal 2015 was 30% of annual base salary, weighted 75% towards corporate goals and
25% towards individual performance. Mr.&nbsp;Ross&#146; individual performance assessment was based on provision of support to facilitate business objectives, responsibility for the Company&#146;s financial statements and compliance with applicable
Securities and Exchange Commission requirements and monitoring and optimizing the Company&#146;s operating costs to meet or exceed the Company&#146;s financial goals. The CEO recommended and the Compensation Committee approved an individual
performance score of 100% for Mr.&nbsp;Ross. Based on the corporate performance score, his individual performance score and his target payout, Mr.&nbsp;Ross received a fiscal 2015 annual bonus of $47,875, equal to approximately 19% of his fiscal
2015 base salary. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Equity Incentive Compensation Granted for Fiscal 2015</I>. In July 2014, the Compensation Committee awarded time and service-based options
to Dr.&nbsp;Ashton, Ms.&nbsp;Freedman and Mr.&nbsp;Ross, subject to shareholder approval in the case of Dr.&nbsp;Ashton. The Compensation Committee believes that stock options are the appropriate equity award at this time because stock options
reward our Named </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
Executive Officers only if our stock price increases above the exercise price of the stock option (the market price on NASDAQ at the close of business on the date of grant). Stock options are
therefore an effective method of motivating and incentivizing recipients to manage our Company in a manner that is consistent with the long term interest of our stockholders. The Compensation Committee also intended that these grants reward the
performance of our Named Executive Officers in fiscal 2014 and provide retention. In light of the Company&#146;s performance against the fiscal year 2014 corporate goals, the retention effect of our Named Executive Officers&#146; unvested option
value, Radford&#146;s recommendations and the Company&#146;s compensation philosophy, the Compensation Committee granted the following time and service-based options with exercise prices at fair market value on the date of grant: 245,000 for
Dr.&nbsp;Ashton, approximately the 50th percentile of the FY2015 Market Consensus, 75,000 for Ms.&nbsp;Freedman, slightly over the 50th percentile of the FY2015 Market Consensus and 45,000 for Mr.&nbsp;Ross, approximately 150% of the 50th percentile
of the FY2015 Market Consensus. On a termination of Dr.&nbsp;Ashton, Ms.&nbsp;Freedman or Mr.&nbsp;Ross&#146; employment without cause by the Company or upon his or her resignation from the Company for good cause, any unvested portion of these
options that would have vested as of the first anniversary of the cessation of his or her employment would vest immediately prior to such cessation of employment and the remaining unvested portion of the option would be forfeited.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Fiscal 2016 Base Salary, Bonus Target and Long Term Equity Incentive Compensation </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2015, the Compensation Committee engaged Radford to conduct a new benchmarking study for fiscal 2016. In July 2015, following a
review and analysis of our executive compensation program, Radford presented the Compensation Committee with a report and recommendations on executive compensation for fiscal 2016. Radford&#146;s recommendations included a market analysis of base
salaries, total cash compensation and equity compensation relative to a market consensus (FY2016 Market Consensus) based on the peer group discussed below as well as peer data derived from the published Radford Global Life Sciences Survey
representing public biotechnology and pharmaceutical companies with fewer than 150 employees, weighted equally. The Compensation Committee used Radford&#146;s recommendations as a starting point to consider market competitiveness and ultimately sets
compensation after also considering individual and Company performance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The peer group selected by the Compensation Committee
for fiscal 2016 was composed of 20 public, biopharmaceutical companies selected based on a comparable business and financial profile to us, including stage of development, employee size, annual revenues and market value. The fiscal 2016 peer group
included, Aerie Pharmaceuticals, Agenus, Alimera Sciences, Anthera Pharmaceuticals, ArQule, CEL-SCI, Celsion, Cumberland Pharmaceuticals, Curis, Cytori Therapeutics, CytRx, DURECT, Hemispherx BioPharma, Heron Therapeutics, Ocothyreon, Pozen, Proteon
Therapeutics, Sunesis Pharmaceuticals, Vermillion and Vical. Our peer group was recommended by Radford and approved by the Compensation Committee. The fiscal 2016 peer group did not include four companies used in the fiscal 2015 peer group:
Transcept Pharmaceuticals, which was acquired, as well as Acura Pharmaceuticals, Alexza Pharmaceuticals and OncoGenex Pharmaceuticals, which no longer had a business or a financial profile comparable to ours. The fiscal 2016 peer group added four
new comparator companies to the fiscal 2015 peer group: Aerie Pharmaceuticals, Curis, Proteon Therapeutics and Vical. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">For fiscal 2016, the Compensation Committee targeted base salary and total compensation of our executive officers around the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of FY2016 Market Consensus, but limited by a maximum increase of 3% from fiscal 2015 base salaries.
Dr.&nbsp;Ashton&#146;s fiscal 2016 base salary remained at $463,500, 8% percent below the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"> percentile of the FY2016 Market Consensus. Fiscal 2016 base salary was increased to $350,097 for Ms.&nbsp;Freedman, 1% percent above the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the FY2016 Market Consensus and an increase of 3% from Ms.&nbsp;Freedman&#146;s fiscal 2015 base salary,
and $255,234 for Mr.&nbsp;Ross, 1% percent above the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
percentile of the FY2016 Market Consensus and an increase of 3% from Mr.&nbsp;Ross&#146; fiscal 2015 base salary. The Compensation Committee set fiscal 2016 target bonus percentages at 55% for Dr.&nbsp;Ashton, 35% for Ms.&nbsp;Freedman and 30% for
Mr.&nbsp;Ross, at the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the FY2016 Market
Consensus, which together with fiscal 2016 base salary, </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">
positioned total target cash compensation levels between the
25</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> and 50</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentiles of the FY2016 Market Consensus for Dr.&nbsp;Ashton, at
the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the FY2016 Market Consensus for
Ms.&nbsp;Freedman and 1% above the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the
FY2016 Market Consensus for Mr.&nbsp;Ross. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2015, the Compensation Committee awarded time and
service-based options to Dr.&nbsp;Ashton, Ms.&nbsp;Freedman and Mr.&nbsp;Ross, subject to shareholder approval in the case of Dr.&nbsp;Ashton. The Compensation Committee believes that stock options are the appropriate equity award at this time
because stock options reward our Named Executive Officers only if our stock price increases above the exercise price of the stock option (the market price on NASDAQ at the close of business on the date of grant). Stock options are therefore an
effective method of motivating and incentivizing recipients to manage our Company in a manner that is consistent with the long term interest of our stockholders. The Compensation Committee also intended that these grants provide retention. In light
of Radford&#146;s recommendations, the Company&#146;s compensation philosophy and the retention effect of our Named Executive Officers&#146; unvested option value, the Compensation Committee granted time and service-based options at the 50</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the FY2016 Market Consensus for each of
Dr.&nbsp;Ashton, Ms.&nbsp;Freedman and Mr.&nbsp;Ross with exercise prices at fair market value on the date of grant as follows: 290,000 for Dr.&nbsp;Ashton, 80,000 for Ms.&nbsp;Freedman and 40,000 for Mr.&nbsp;Ross. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Termination-Based Compensation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to their employment agreements, Dr.&nbsp;Ashton, Ms.&nbsp;Freedman and Mr.&nbsp;Ross are entitled to severance payments in certain circumstances described under &#147;Potential Payments upon
Termination or Change in Control.&#148; We believe that it is important to define the relative obligations of pSivida and these Named Executive Officers, including obtaining protection against competition and solicitation, and that severance
protections assist in attracting and retaining high quality executives and in keeping them focused on their responsibilities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Tax and
Accounting Considerations </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended (Section 162(m)), generally
disallows a tax deduction for individual compensation in excess of $1.0 million in any taxable year paid to our CEO and the three other most highly compensated executive officers, other than our chief financial officer, unless the compensation
qualifies as performance-based under Section&nbsp;162(m). Our Board and Compensation Committee may take into consideration the potential deductibility of the compensation payable under our compensation programs as one of the factors to be considered
when establishing and administering these programs. We generally structure the value of our cash and stock compensation to fall below this limit, and our stock options to comply with exemptions in Section&nbsp;162(m), so that the compensation
remains tax deductible to us. However, our Board or Compensation Committee may, in their judgment, authorize compensation payments that do not comply, in whole or in part, with the performance-based exemptions in Section&nbsp;162(m) or that may
otherwise be limited as to tax deductibility when they believe that such payments are appropriate to attract and retain executive talent. Our Board and Compensation Committee regularly consider the accounting implications of significant compensation
decisions, especially in connection with decisions that relate to our equity incentive award plans and programs. As accounting standards change, we may revise certain programs to appropriately align accounting expenses of our equity awards with our
overall executive compensation philosophy and objectives. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Prohibition of Hedging and Pledging of our Stock </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Insider Trading Policy prohibits our employees, including our executive officers, and directors from engaging in transactions designed
to offset decreases in the market value of our stock, including certain forms of hedging and monetization transactions, such as &#147;collars&#148; and &#147;prepaid variable forward contracts.&#148; Our policy also prohibits employees, including
our executive officers, and directors from pledging our securities as collateral for a loan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stock Ownership Guidelines </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective September&nbsp;25, 2015, our Board, upon the recommendation of the Compensation Committee, adopted stock ownership guidelines
for our executive officers. These guidelines were established to further align the interests of our executive officers with those of our stockholders and to promote our commitment to sound corporate governance practices. The ownership guidelines for
our executive officers are listed below: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Multiple&nbsp;of&nbsp;Base&nbsp;Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3x</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each other Executive Officer covered by the Guidelines</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1x</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Owned shares as well as shares underlying vested stock options, to the extent such options are
&#147;in-the-money,&#148; unvested restricted shares (including performance shares) and vested restricted shares are counted towards meeting the guidelines. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">All executive officers have five years from the later of the effective date of these guidelines or their appointment as a Section&nbsp;16 officer to meet these guidelines, and their stock ownership is
reviewed annually by the Compensation Committee. For all of our current executive officers, the compliance deadline is September&nbsp;25, 2020, but we expect the target stock ownership levels will likely be achieved before then. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10b5-1 Plans </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of
our executive officers is required to receive the permission of our general counsel prior to entering into any transactions in our securities. Generally, trading is permitted only during announced trading windows. Employees subject to trading
restrictions, including our Named Executive Officers, may enter into trading plans under Rule 10b5-1 of the 1934 Act, provided the plans are entered into during an open trading window and approved by us. Certain of our executive officers are, and in
the future these officers and other executive officers may be, parties to 10b5-1 plans. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee Processes and Procedures
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee is responsible for overseeing executive compensation and benefits; it administers, reviews and
approves, or, as it determines appropriate, recommends to the Board, any changes in individual compensation of executive officers, general compensation policies and equity and incentive plans. The Compensation Committee has the authority to obtain
advice and assistance from internal or external legal, accounting or other advisors, and to authorize payment of any such advisors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Named Executive Officers had limited involvement in determining or recommending the amount or form of executive compensation in fiscal 2015 as described above. No executive may be involved in, or
present during, deliberations or voting on his or her own compensation. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Compensation </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following tables, footnotes and narratives provide information regarding the compensation, benefits and equity holdings in pSivida of
our Named Executive Officers. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary Compensation </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table and footnotes provide additional information concerning the compensation of our Named Executive Officers for the
fiscal years ended June&nbsp;30,&nbsp;2015, 2014 and 2013. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:97pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards<BR>($)<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(3)</SUP>
</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other<BR>Compensation&nbsp;($)<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul Ashton</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">463,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">133,836</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">815,528</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,888</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,425,752</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>President and Chief</I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Executive Officer</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">450,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">258,638</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">417,192</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,074</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,140,904</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">412,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">316,300</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">98,428</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,237</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">839,965</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lori Freedman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">339,929</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76,620</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">258,343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,055</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">687,947</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="4"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vice&nbsp;President&nbsp;for</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Corporate&nbsp;Affairs,</I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>General Counsel and</I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Company Secretary</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">330,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">103,464</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">189,535</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">637,226</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">319,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">147,080</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,175</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">552,155</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Leonard S. Ross</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">247,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">47,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">155,006</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">463,861</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vice President, Finance</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">240,583</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,423</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">108,305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,268</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">438,579</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">218,712</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">83,955</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">39,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,384</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">353,651</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in this column reflect the aggregate grant date fair value of equity awards granted during the applicable fiscal year, calculated in accordance with FASB
ASC Topic 718 and using a Black-Scholes valuation model. Assumptions used in the calculation of these amounts are included in Note 10 of the audited financial statements filed with our Annual Report on Form&nbsp;10-K for fiscal 2015.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These amounts reflect fiscal 2013 bonuses (paid at 105% of target) as well as fiscal 2012 bonuses (paid at 50% of target after achievement of additional performance
conditions in fiscal 2013): </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fiscal</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013 bonuses: Dr.&nbsp;Ashton ($216,300), Ms.&nbsp;Freedman ($100,580) and Mr.&nbsp;Ross ($57,412) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fiscal</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012 bonuses: Dr.&nbsp;Ashton ($100,000), Ms.&nbsp;Freedman ($46,500) and Mr.&nbsp;Ross ($26,543) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These amounts reflect valuation at the date of shareholder approval in the case of Dr.&nbsp;Ashton and the grant date in the case of Ms.&nbsp;Freedman and
Mr.&nbsp;Ross. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of 401(k) contributions and group term life insurance premiums, as detailed below: </FONT></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:97pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Company&nbsp;Paid<BR>Amounts for<BR>Life&nbsp;Insurance<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Company<BR>Contributions<BR>to&nbsp;401(k)&nbsp;Plan<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul Ashton</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,372</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,888</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>President and Chief Executive Officer</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,558</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,074</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">462</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,775</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,237</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lori Freedman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,539</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,055</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vice&nbsp;President&nbsp;for Corporate Affairs,</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>General Counsel and Company Secretary</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,683</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">462</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,175</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Leonard S. Ross</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,664</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vice President, Finance</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,752</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,268</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">462</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,922</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,384</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During fiscal years&nbsp;2015, 2014 and 2013, Dr.&nbsp;Ashton, Ms.&nbsp;Freedman and Mr.&nbsp;Ross were
employed under employment agreements with the Company, pursuant to which they received the annual base salaries indicated in </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the above Summary Compensation table. The employment agreements of Dr.&nbsp;Ashton, Ms.&nbsp;Freedman and Mr.&nbsp;Ross also provided for discretionary bonuses, discretionary stock option grants,
life insurance and matching 401(k) contributions consistent with other U.S. employees and participation in our medical, dental and life and disability insurance plans. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Grants of Plan-Based Awards </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table and footnotes provide
information concerning grants of plan-based awards to our Named Executive Officers during the fiscal year ended June&nbsp;30,&nbsp;2015. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other<BR>Stock&nbsp;Awards;<BR>Number of<BR>Shares of<BR>Stock or<BR>Units</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Option&nbsp;Awards;<BR>Number of<BR>Securities<BR>Underlying<BR>Options<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise<BR>Price<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></B></FONT>
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant&nbsp;Date<BR>Fair Value<BR>of Stock<BR>and<BR>Option<BR>Awards<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul Ashton</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/15/14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">245,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">815,528</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>President and Chief Executive Officer</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lori Freedman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/15/14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">258,343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vice&nbsp;President&nbsp;for Corporate&nbsp;Affairs,</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>General Counsel and Company Secretary</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Leonard S. Ross</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/15/14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">155,006</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vice President, Finance</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These option awards vest in four equal annual installments, commencing on the first anniversary of the date of grant. In addition, in the event of involuntary
termination without cause or a voluntary termination for good cause, any unvested portion of the options that would have vested as of the first anniversary of the employment termination instead would vest immediately prior to the employment
termination, and if such termination occurs within 24 months after a change of control, all options automatically would vest and remain exercisable until the earlier of (i)&nbsp;one year and (ii)&nbsp;the option expiration date.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The exercise price reflects the closing market price of our common stock on the date of grant. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The grant date fair value of option grants is calculated in accordance with FASB ASC Topic 718 and using a Black-Scholes valuation model, including valuation at the
date of shareholder approval in the case of Dr.&nbsp;Ashton and at the grant date in the case of Ms.&nbsp;Freedman and Mr.&nbsp;Ross. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Outstanding Equity Awards at Fiscal Year-End </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table and footnotes provide information concerning outstanding equity awards for our Named Executive Officers as of
June&nbsp;30,&nbsp;2015: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Securities&nbsp;Underlying&nbsp;Unexercised<BR>Options (#)<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price&nbsp;($)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Unexercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Unearned</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul Ashton</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">210,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11/18/18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>President and Chief Executive Officer</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">315,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.01</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11/19/19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">87,380</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/22/20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">101,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,750</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.05</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/21/21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/18/22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46,350</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,050</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/23/23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">245,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/15/24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lori Freedman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">09/04/18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vice&nbsp;President&nbsp;for Corporate&nbsp;Affairs,</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.77</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">09/10/18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>General Counsel and Company Secretary</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.81</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">06/25/19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46,325</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/22/20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.05</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/21/21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/18/22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,500</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/23/23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/15/24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Leonard S. Ross</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">09/11/18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vice President, Finance</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.81</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">06/25/19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/22/20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,250</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.05</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/21/21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/18/22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/23/23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">07/15/24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The option numbers represent options to acquire shares of common stock. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Ashton&#146;s unexercisable options vest and become exercisable as follows: 33,750 on July&nbsp;21, 2015, 52,000 in two equal annual installments commencing
July&nbsp;18, 2015, 139,050 in three equal annual installments commencing July&nbsp;23, 2015 and 245,000 in four equal annual installments commencing July&nbsp;15, 2015. These options also vest on involuntary termination without cause and voluntary
termination by Dr.&nbsp;Ashton for good cause as described below. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Freedman&#146;s unexercisable options vest and become exercisable as follows: 15,000 on July&nbsp;21, 2015, 22,000 in two equal annual installments commencing
July&nbsp;18, 2015, 52,500 in three equal annual installments commencing July&nbsp;23, 2015 and 75,000 in four equal annual installments commencing July&nbsp;15, 2015. These options also vest on involuntary termination without cause and voluntary
termination by Ms.&nbsp;Freedman for good cause as described below. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Ross&#146;s unexercisable options vest and become exercisable as follows: 6,250 on July&nbsp;21, 2015, 12,000 in two equal annual installments commencing
July&nbsp;18, 2015, 30,000 in three equal annual installments commencing July&nbsp;23, 2015 and 45,000 in four equal annual installments commencing July&nbsp;15, 2015. These options also vest on involuntary termination without cause and voluntary
termination by Mr.&nbsp;Ross for good cause as described below. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Option Exercises and Stock Vested </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth information regarding the number and value of stock options exercised and the number and value of restricted stock units
vested during fiscal 2015 for each of our Named Executive Officers. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Exercise&nbsp;(#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value<BR>Realized&nbsp;on<BR>Exercise<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Vesting&nbsp;(#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value<BR>Realized&nbsp;on<BR>Vesting</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul Ashton</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">132,179</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lori Freedman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Leonard S. Ross</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value realized on exercise of options calculated based upon the difference between the selling price of the shares of common stock underlying the options on the date of
exercise and the option exercise price. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Pension Benefits </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We do not have any qualified or non-qualified defined benefit plans. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Non-qualified Deferred Compensation </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We do not have any non-qualified defined contribution plans or other deferred compensation plans. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Potential Payments upon Termination or Change in Control </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Ashton,
Ms.&nbsp;Freedman and Mr.&nbsp;Ross have contracts with us that provide for potential payments in connection with termination by us without cause or resignation for good cause. If the severance provisions in these contracts had been triggered on
June&nbsp;30,&nbsp;2015, Dr.&nbsp;Ashton, Ms.&nbsp;Freedman and Mr.&nbsp;Ross would have been entitled to payments in the following amounts: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:95pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Triggering Event / Payment</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Paul&nbsp;
Ashton<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(2)(3)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Lori&nbsp;
Freedman<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)(3)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Leonard&nbsp;S.&nbsp;
Ross<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)(3)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Termination without Cause / Constructive Termination</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Salary</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">463,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">339,929</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">185,850</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bonus</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">254,925</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">222,439</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74,340</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Medical / Life / Disability Insurance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,425</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,089</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,336</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Unvested Option Awards</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,431</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,480</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,380</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">801,281</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">612,937</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">291,906</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Change in Control followed by Termination</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Salary</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">463,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">339,929</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">247,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bonus</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">254,925</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">222,439</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">149,763</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Medical / Life / Disability Insurance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,425</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,089</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,336</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Unvested Option Awards</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,913</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,510</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,360</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">867,763</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">639,967</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">444,259</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The above table does not take into account up to $800,000 that Dr.&nbsp;Ashton could receive if we exercised our right under our non-competition agreement with
Dr.&nbsp;Ashton to require him not to compete with us for a period of up to 24&nbsp;months. Any severance or other payments owed to Dr.&nbsp;Ashton in connection with the termination of his employment as described in his non-competition agreement
would result in a dollar-for-dollar reduction in the amount paid to Dr.&nbsp;Ashton under this non-competition agreement. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The above table assumes lump-sum payments for one year of medical, dental, life and disability insurance premiums for Dr.&nbsp;Ashton,
Ms.&nbsp;Freedman and Mr.&nbsp;Ross, and does not take into account potential increases in insurance premiums. The table also assumes that Dr.&nbsp;Ashton, Ms.&nbsp;Freedman and Mr.&nbsp;Ross would elect their
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
current coverages under our employee benefit plans and would not obtain coverage from another employer. For purposes of quantifying medical, dental, life and disability insurance benefits, we
have used the assumptions used for financial reporting purposes under generally accepted accounting principles. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The above table values the acceleration of unvested in-the-money option awards using the spread between (i)&nbsp;the relevant option exercise price and (ii)&nbsp;the
closing price of our common stock on NASDAQ on June&nbsp;30, 2015, which was $3.77. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The severance arrangements
of each of our Named Executive Officers as of June&nbsp;30, 2015 are further described in the following paragraphs. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Paul Ashton
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Termination of Dr.&nbsp;Ashton&#146;s employment by us without cause, or by Dr.&nbsp;Ashton with good cause, would require
us to pay severance to Dr.&nbsp;Ashton. Dr.&nbsp;Ashton would be entitled to a lump sum payment equal to 100% of his current annual salary plus the pro rata portion of his bonus for the year of such termination, calculated on the assumption that all
targets and formulas for determining such bonus had been met, or, if no such targets or formulas had been established, the maximum bonus for which he was eligible during the prior year calculated on the same assumption. The bonus payable would be
reduced by any bonus payments relating to services performed in the year in which termination occurred (1)&nbsp;that already had been paid or were payable as of the date of termination or (2)&nbsp;that were not earned because of the failure to
achieve targets or formulas that were no longer able to be achieved. The bonus payable also would exclude any bonus paid or payable in the year in which termination occurred with respect to services rendered in a prior year. We also would be
required to provide Dr.&nbsp;Ashton with medical, life and disability insurance benefits for a period of one year if he elected coverage. Additionally, with respect to options held by Dr.&nbsp;Ashton, any unvested portion that would have vested as
of the first anniversary following the date of his termination by us without cause or by Dr.&nbsp;Ashton with good cause (other than within 24 months of a change in control) would vest upon any such termination, and such options would remain
exercisable until the earlier of (i)&nbsp;three months thereafter and (ii)&nbsp;the applicable option expiration date. Upon any such termination within 24 months of a change in control, any unvested portion of options held by Dr.&nbsp;Ashton would
vest and become exercisable upon such termination, and such options would remain exercisable until the earlier of (i)&nbsp;one year thereafter and (ii)&nbsp;the applicable option expiration date. Termination by us for cause, or by Dr.&nbsp;Ashton
without good cause, would not require us to pay any severance to Dr.&nbsp;Ashton. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Ashton has a separate
non-competition agreement with us. Under this agreement, following a termination by us for cause, or by Dr.&nbsp;Ashton without good cause, Dr.&nbsp;Ashton would be required not to engage in certain activities that would be in competition with us
for a period of twelve months from the date of termination. No additional consideration is required to be paid by us for this period. We could at our option extend this period for an additional twelve months, in which case we would be required to
pay Dr.&nbsp;Ashton an amount equal to his annual base salary as of the date of termination in twelve equal installments over the course of the additional twelve-month period. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under Dr.&nbsp;Ashton&#146;s non-competition agreement, following a termination by us without cause, or by Dr.&nbsp;Ashton for good cause, we would have the option to prevent him from engaging in certain
activities that would be in competition with us for a period of up to twenty-four months from the date of such termination. In exchange, we would pay Dr.&nbsp;Ashton an amount equal to 1/24th of $800,000 for each month in the period specified. Any
amounts received by Dr.&nbsp;Ashton pursuant to his severance arrangement with us would reduce the amount that we were required to pay under his non-competition agreement on a dollar-for-dollar basis. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Lori Freedman </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Termination of Ms.&nbsp;Freedman&#146;s employment by us without cause, or by Ms.&nbsp;Freedman with good cause, would require us to pay
severance to Ms.&nbsp;Freedman. Ms.&nbsp;Freedman would be entitled to a lump sum payment equal to the sum of (1)&nbsp;100% of current annual salary, (2)&nbsp;an amount equal to the greater of the prior year&#146;s
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
bonus and the bonus for the year preceding that year and (3)&nbsp;a pro rata portion of the current year&#146;s bonus, calculated on the assumption that all targets and formulas for determining
such bonus had been met, or, if no such targets or formulas were established, calculated as a pro rata portion of the prior year&#146;s bonus. This lump sum payment may be made either in cash, or, at our election, 50% in cash and 50% in stock. We
also would be required to provide medical, life and disability benefits to Ms.&nbsp;Freedman for a period of one year if she so elected. Additionally, with respect to options held by Ms.&nbsp;Freedman, any unvested portion that would have vested as
of the first anniversary following the date of her termination by us without cause or by Ms.&nbsp;Freedman with good cause (other than within 24 months of a change in control) would vest upon any such termination, and such options would remain
exercisable until the earlier of (i)&nbsp;three months thereafter and (ii)&nbsp;the applicable option expiration date. Upon any such termination within 24 months of a change in control, any unvested portion of Ms.&nbsp;Freedman&#146;s options would
vest and become exercisable upon such termination, and such options would remain exercisable until the earlier of (i)&nbsp;one year thereafter and (ii)&nbsp;the applicable option expiration date. Termination by us for cause or by Ms.&nbsp;Freedman
without good cause would not require us to pay any severance to Ms.&nbsp;Freedman. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Leonard S. Ross </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Termination of Mr.&nbsp;Ross&#146; employment by us without cause, or by Mr.&nbsp;Ross with good cause, would require us to pay severance
to Mr.&nbsp;Ross. Upon any such termination (other than within 24 months of a change of control), provided that at the Company&#146;s election Mr.&nbsp;Ross remains an employee for up to nine months after notifying the Company of a good cause
termination, Mr.&nbsp;Ross would be entitled to a lump sum payment equal to the sum of (1)&nbsp;75% of current annual salary and (2)&nbsp;a pro rata portion of the current year&#146;s bonus, calculated based on the period from the commencement of
the fiscal year until the termination date and further calculated on the assumption that all targets and formulas for determining such bonus had been met, or, if no such targets or formulas were established, calculated as a pro rata portion of the
prior year&#146;s bonus. We also would be required to provide medical, life and disability benefits to Mr.&nbsp;Ross for a period of one year if he so elected. Additionally, with respect to all options held by Mr.&nbsp;Ross, any unvested portion
that would have vested as of the first anniversary following the date of his termination by us without cause or by Mr.&nbsp;Ross with good cause would vest upon any such termination, and such options would remain exercisable until the earlier of
(i)&nbsp;three months thereafter and (ii)&nbsp;the applicable option expiration date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the event of any such termination
within 24 months of a change in control, Mr.&nbsp;Ross would be entitled to a lump sum payment equal to the sum of (1)&nbsp;100% of current annual salary, (2)&nbsp;an amount equal to the prior year&#146;s bonus and (3)&nbsp;a pro rata portion of the
current year&#146;s bonus, calculated based on the period from the commencement of the fiscal year until the termination date and further calculated on the assumption that all targets and formulas for determining such bonus had been met, or, if no
such targets or formulas were established, calculated as a pro rata portion of the prior year&#146;s bonus, as well as medical, life and disability benefits to Mr.&nbsp;Ross for a period of one year if he so elected. In addition, upon any such
termination within 24&nbsp;months of a change in control, any unvested portion of Mr.&nbsp;Ross&#146; options would vest and become exercisable upon such termination, and such options would remain exercisable until the earlier of (i)&nbsp;one year
thereafter and (ii)&nbsp;the applicable option expiration date. Termination by us for cause or by Mr.&nbsp;Ross without good cause would not require us to pay any severance to Mr.&nbsp;Ross. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Director Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table and footnotes provide information regarding the compensation paid to our non-executive directors for the fiscal year ended June&nbsp;30,&nbsp;2015: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned&nbsp;or<BR>Paid&nbsp;in&nbsp;Cash&nbsp;($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards($)<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(2)</SUP></B>
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David J. Mazzo</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">86,941</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">161,169</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">James Barry</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">39,185</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">123,623</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">162,808</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael Rogers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57,961</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,961</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter G. Savas</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">56,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57,961</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">113,961</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Douglas Godshall</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">69,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57,961</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">126,961</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reflect the grant date fair values of fiscal 2015 option awards as determined in accordance with FASB ASC Topic 718. The underlying valuation assumptions for
equity awards are further disclosed in Note&nbsp;10 of the audited financial statements filed with our Annual Report on Form&nbsp;10-K for fiscal 2015. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows the number of outstanding shares underlying outstanding options held by our non-executive directors as of June&nbsp;30,&nbsp;2015:
</FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Outstanding<BR>Option&nbsp;Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David J. Mazzo</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">375,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">James Barry</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael Rogers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">270,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter G. Savas</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">230,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Douglas Godshall</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Compensation for non-executive directors for fiscal 2015 is: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annual retainer fee of $60,000 for the Board chair and $40,000 for each other Board member; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annual retainer fee of $20,000 for the chair and $8,000 for each other member of the Audit and Compliance Committee; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annual retainer fee of $12,000 for the chair and $6,000 for each other member of the Compensation Committee; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annual retainer fee of $8,000 for the chair and $4,000 for each other member of the Governance and Nominating Committee; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annual retainer fee of $8,000 for the chair and $4,000 for each other member of the Science Committee; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">in the event a director attends more than twelve committee meetings, meeting attendance fees of $1,000 for each Board and committee meeting attended
thereafter; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">initial grant of an option to purchase 40,000 shares for a new director and annual grants of options to purchase 30,000&nbsp;shares for the Board chair
and 20,000&nbsp;shares for other directors, all subject to stockholder approval. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Ashton received
no additional compensation for serving as a director. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_7"></A>PROPOSAL 2: APPROVAL OF OPTION GRANT TO CEO </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee provides annual equity incentives to our executive officers as part of their annual compensation. The
Compensation Committee granted Dr.&nbsp;Ashton an option to purchase 290,000 shares of common stock under the 2008 Incentive Plan on the terms detailed below, subject to stockholder approval. The Committee determined the amount and terms of the
grant with advice from its independent compensation consultant Radford and considered peer group and survey information. The award was designed to incentivize his future performance and to promote his retention. Because Dr.&nbsp;Ashton is a
director, ASX Listing Rules require stockholder approval of his option grant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has made the option grant subject
to stockholder approval and will issue the option certificate within one month of stockholder approval. The option grant to Dr.&nbsp;Ashton will not have any effect upon the rights of existing security holders, except a potential reduction of each
existing security holder&#146;s percentage ownership in pSivida of up to approximately 0.98% of such security holder&#146;s percentage ownership. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>The Board recommends that you vote FOR proposal 2, the approval of the option grant to Dr.&nbsp;Ashton. </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Material Terms of the Proposed Grant </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Ashton&#146;s option has an
exercise price of $4.09 per share, equal to the closing price on NASDAQ of a share of our common stock on July&nbsp;23, 2015, the date of grant. The option vests and becomes exercisable in four equal installments on the first through fourth
anniversaries of the date of grant. This option, if not earlier forfeited, expires on the tenth anniversary of the date of grant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If Dr.&nbsp;Ashton&#146;s employment were terminated by reason of an involuntary termination without cause or a voluntary termination for good cause, any unvested portion of the option granted to him that
would have vested as of the first anniversary of the employment termination instead would vest immediately prior to the employment termination and remain exercisable until the earlier of (i)&nbsp;three months thereafter and (ii)&nbsp;the applicable
option expiration date. If Dr.&nbsp;Ashton&#146;s employment were terminated within 24 months after a change of control by reason of an involuntary termination without cause or a voluntary termination for good cause, the option granted to him
automatically would vest and remain exercisable until the earlier of (i)&nbsp;one year following such termination and (ii)&nbsp;the option expiration date. The option is subject to the terms of the 2008 Incentive Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The proposed grant is being issued for no cash consideration and there are no loans being made in relation to the proposed grant.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_8"></A>PROPOSAL 3: APPROVAL OF OPTION GRANTS TO NON-EXECUTIVE DIRECTORS
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has granted, subject to stockholder approval, options to our five non-executive directors
under the 2008 Incentive Plan in the amount of 30,000 shares for David J. Mazzo, the chairman of our Board, and 20,000 shares of common stock for each of Douglas Godshall, Michael Rogers, Peter Savas and James Barry. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has determined that an annual grant to existing directors of an option to purchase 20,000 shares is
appropriate to retain high-quality directors and is consistent with competitive director equity compensation in peer companies. The Compensation Committee further has determined that the larger option grant of 30,000 shares to the chairman of the
Board is appropriate to reflect the additional contribution and time commitment of that role. In determining each of these option grants, the Compensation Committee sought the advice of compensation consulting firm Radford and considered peer group
and survey information. Option grants to directors require stockholder approval under ASX Listing Rules. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has made
these option grants subject to stockholder approval and will issue the option certificates within one month of stockholder approval. The option grants will not have any effect upon the rights of existing security holders, except a potential
reduction of each existing security holder&#146;s percentage ownership in pSivida of up to approximately 0.37% of such security holder&#146;s percentage ownership. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The option grants are independent of one another, and each proposal will be voted on separately as follows: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3.1 &#150; grant of options to James Barry </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3.2 &#150; grant of options to Douglas Godshall </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3.3 &#150; grant of options to Michael Rogers </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3.4 &#150; grant of options to Peter G. Savas </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3.5 &#150; grant of options to David J. Mazzo </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>The Board recommends that you vote FOR proposals 3.1, 3.2, 3.3. 3.4 and 3.5, the approval of the option grants to each of Dr.&nbsp;Barry, Mr.&nbsp;Godshall, Mr.&nbsp;Rogers, Mr.&nbsp;Savas and
Dr.&nbsp;Mazzo. </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Material Terms of the Option Grants </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The option grants to Dr.&nbsp;Barry, Mr.&nbsp;Godshall, Mr.&nbsp;Rogers, Mr.&nbsp;Savas and Dr.&nbsp;Mazzo each have an exercise price of $4.09 per share, equal to the closing price on NASDAQ of a share
of our common stock on July&nbsp;23, 2015, the date of grant. These options vest and become exercisable on July&nbsp;23, 2016, the first anniversary of the date of grant, and expire on the tenth anniversary of the date of grant. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If a director&#146;s Board service is terminated after a change of control, the option granted to that director automatically vests and
remains exercisable until the earlier of (i)&nbsp;one year following such termination and (ii)&nbsp;the option expiration date. The options are subject to the terms of the 2008 Incentive Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The proposed grants are being issued for no cash consideration. There are no loans being made in relation to the proposed grants, and no
directors or associates of directors have received securities under the pSivida Corp. 2008 Incentive Plan since the last grants approved by stockholders (which were options to our five non-executive directors under the 2008 Incentive Plan in the
amount of 30,000 shares for Dr.&nbsp;Mazzo, 20,000 shares for each of Mr.&nbsp;Rogers, Mr.&nbsp;Savas and Mr.&nbsp;Godshall and 40,000 shares for Dr.&nbsp;Barry). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_9"></A>PROPOSAL 4: ADVISORY VOTE ON EXECUTIVE COMPENSATION
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As required under Section&nbsp;14A of the Exchange Act, the Board of Directors is submitting a &#147;say on pay&#148;
proposal for stockholder consideration. While the vote on executive compensation is nonbinding and advisory, the Board and the Compensation Committee value the opinion of our stockholders, and to the extent there is any significant vote against the
executive officer compensation as disclosed in this proxy statement, we will consider our stockholders&#146; concerns and evaluate what actions may be appropriate to address those concerns. The Company&#146;s current policy is to provide
shareholders with an opportunity to approve the compensation of our Named Executive Officers each year at the annual meeting of shareholders. It is expected that the next such vote will occur at the 2016 annual meeting of shareholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive compensation is an important matter for stockholders. The core of the Company&#146;s executive compensation philosophy and
practice is weighted to at-risk incentive compensation earned on the basis of performance and continues to balance elements of compensation to incentivize performance and promote retention. We believe our executive officers are compensated in a
manner consistent with our strategy, competitive practice, sound corporate governance principles, and stockholder interests and concerns. Compensation of our executive officers takes into account Company performance, individual contribution and peer
compensation and is designed to enable the Company to attract and retain talented and experienced senior executives to lead the Company successfully in a competitive environment. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The compensation of our Named Executive Officers is described starting on page 12 of this Proxy Statement, which includes the
Compensation Discussion and Analysis, or CD&amp;A. The CD&amp;A provides additional details on executive compensation, including the Company&#146;s compensation philosophy and objectives, and the fiscal 2015 compensation of our Named Executive
Officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company is asking stockholders to vote on the following resolution: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;<B>RESOLVED</B>, that the Company&#146;s stockholders approve, on an advisory basis, the compensation of our Named Executive
Officers as disclosed in the proxy statement for the 2015 Annual Meeting of Stockholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission (which disclosure includes the Compensation Discussion and Analysis, the
Summary Compensation Table for fiscal 2015, and the other related tables and disclosures).&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors
unanimously recommends stockholders vote, on an advisory basis, FOR the Company&#146;s 2015 executive compensation. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_10"></A>PROPOSAL 5: RATIFICATION OF APPOINTMENT OF </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Audit and Compliance Committee has appointed Deloitte&nbsp;&amp; Touche LLP (Deloitte) to serve as our independent registered public accounting firm and to audit our financial statements and our
internal control over financial reporting for fiscal 2016. Although ratification is not required, we are seeking stockholder approval of the selection as a matter of good corporate practice. If stockholders do not ratify the appointment, then the
Audit and Compliance Committee will consider whether it is appropriate to select a different independent registered public accounting firm or to continue Deloitte&#146;s appointment as our independent registered public accounting firm. Even if
stockholders do ratify the appointment, the Audit and Compliance Committee in its discretion may select a different independent registered public accounting firm at any time during the year, if the Audit and Compliance Committee determines that such
a change would be in our and our stockholders&#146; best interests. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deloitte was our independent registered public accounting
firm for fiscal&nbsp;2015. Deloitte is expected to have a representative present at the Annual Meeting to answer appropriate questions and to make a statement if he or she desires. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board recommends that you vote FOR ratification of Deloitte&#146;s appointment as the independent registered public accounting
firm. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth the total fees paid to Deloitte and its affiliates with respect to fiscal 2015 and
2014: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fiscal&nbsp;Year&nbsp;Ended</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>June&nbsp;
30,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;2015&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;2014&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit fees</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">412</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">391</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit-related fees</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">129</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax fees</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">83</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All other fees</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">530</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">573</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit fees relate to professional services rendered in connection with the annual audit of our consolidated financial statements and internal control over financial
reporting, the reviews of the condensed consolidated financial statements performed in connection with each of our Quarterly Reports on Form 10-Q and the statutory audit of the Company&#146;s wholly-owned subsidiary located in the United Kingdom.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These are fees for assurance and related services that are reasonably related to performance of the audit and review of our financial statements, and which are not
reported under &#147;Audit fees&#148;. These services in fiscal 2015 were related to a comfort letter in connection with our ATM facility. These services in fiscal 2014 were related to our underwritten public offering in July 2013, consummation of
our ATM facility in December 2013 and our registered direct offering in March 2014. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax fees paid to Deloitte for fiscal 2015 and 2014 were related to the preparation of various corporate tax returns as well as tax advice. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">All other fees relates to a subscription to Deloitte&#146;s on-line accounting research database. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our policies require the Audit and Compliance Committee to pre-approve all audit and permitted non-audit services provided by the
independent registered public accounting firm, including engagement fees and terms. The Audit and Compliance Committee may delegate pre-approval authority to one or more of its members, who will report any pre-approval decisions to the full
committee at its next scheduled meeting, but may not delegate pre-approval authority to members of management. The Audit and Compliance Committee may approve only those non-audit services classified as &#147;all other services&#148; that it believes
to be routine and recurring services, to be consistent with SEC rules and to not impair the auditor&#146;s independence with respect to pSivida. The Audit and Compliance Committee reviewed and pre-approved all audit services and permitted non-audit
services performed during fiscal 2015 and 2014. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_11"></A>INFORMATION ABOUT STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder proposals for inclusion in our proxy statement:</I>&nbsp;To be eligible for inclusion in our proxy
statement and form of proxy relating to our 2016 Annual Meeting, stockholder proposals must be submitted pursuant to Securities Exchange Act Rule&nbsp;14a-8 and received at our principal executive offices no later than June&nbsp;29, 2016, which is
120 calendar days before October&nbsp;26, 2016&#151;the anniversary of the date our proxy statement was released to stockholders in connection with the 2015 Annual Meeting. If the date of next year&#146;s annual meeting is changed by more than
30&nbsp;days from the anniversary date of this year&#146;s Annual Meeting on December&nbsp;3, 2015, then the deadline is a reasonable time before we begin to print and mail proxy materials. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Other stockholder proposals:</I>&nbsp;A nomination of one or more persons for election as a director or any other stockholder proposal
not included in our proxy statement for the 2016 Annual Meeting will be ineligible for presentation at the meeting unless the stockholder gives timely notice of the proposal in writing to our Secretary at our principal executive offices and
otherwise complies with the provisions of our By-Laws. To be timely, our By-Laws provide that we must have received the stockholder&#146;s notice: (a)&nbsp;not less than 60&nbsp;days in advance of the meeting if the meeting is to be held on a day
which is within 30 days preceding the anniversary of the 2015 Annual Meeting, (b)&nbsp;not less than 90 days in advance of the meeting if the meeting is to be held on or after the anniversary of the 2015 Annual Meeting, and (c)&nbsp;in any other
cases, not more than 15 days following the date on which notice or public disclosure (as defined in our By-Laws) of the date of the 2016 Annual Meeting is made. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We reserve the right to reject, rule out of order or take other appropriate action with respect to any proposal that does not comply with the foregoing requirements and with the SEC regulations regarding
stockholder proposals. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_12"></A>ADDITIONAL INFORMATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting Requirements and Proxies </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Nominees receiving a plurality of votes properly cast for the election of directors (proposals 1.1-1.6) will be elected directors. All other proposals require approval of a majority of votes properly cast
on the respective proposals. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you vote by Internet, telephone or mail, the person whom you have named proxy will vote your
shares in accordance with your instructions. If you vote by Internet, telephone or mail without providing instructions as to how your vote should be cast, the person whom you have named as proxy will vote in favor of election of all directors and in
favor of the other proposals contained in this proxy statement. However, if your shares are held by a broker or nominee and you do not instruct the broker or nominee, your shares may be counted for purposes of a quorum for the meeting, but the
broker or nominee will vote your shares only with respect to ratification of the appointment of the independent registered public accounting firm (proposal 5) and will not vote your shares with respect to the election of directors (proposals 1.1,
1.2, 1.3, 1.4, 1.5 and 1.6), approval of annual option grant to the CEO (proposal 2), approval of option grants to the non-executive directors (proposals 3.1, 3.2, 3.3, 3.4 and 3.5) or advisory vote on executive compensation (proposal 4), and these
broker non-votes will not affect the outcome of these votes. Abstentions will be counted for purposes of determining the quorum for the meeting but will not affect the outcome of the vote on any proposal. If any other matters are properly presented
for voting at the Annual Meeting, the person whom you have named as proxy will have discretionary authority to vote in accordance with his or her own judgment, including the authority to vote to adjourn the meeting. The person named as proxy will be
able to vote your shares as described above at postponed or adjourned meetings. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting Exclusion Statement </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will disregard any votes cast on proposals 2, 3.1, 3.2, 3.3, 3.4 and 3.5 by any of the directors and any of their associates. We will
not disregard a vote, however, if it is cast (1)&nbsp;by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form or (2)&nbsp;by the person chairing the Annual Meeting as proxy for a person who is
entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Other Business </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">At the time of mailing this proxy statement, we do not know of any other matter that properly may come before the Annual Meeting, and do not intend to present any other matter. However, if any other
matters properly come before the meeting or any adjournment, the persons named as proxies will be able to vote on those matters in accordance with their own judgment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If there are insufficient votes to approve the proposals, your proxy may be voted by the persons named in the proxy to adjourn the Annual Meeting in order to solicit additional proxies in favor of the
approval of such proposals. If the Annual Meeting is adjourned or postponed for any purpose, at any subsequent reconvening of the meeting your proxy will be voted in the same manner as it would have been voted at the original convening of the Annual
Meeting unless you withdraw or revoke your proxy. Your proxy may be voted in this manner even though it may have been voted on the same or any other matter at a previous session of the Annual Meeting. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Proxy Solicitation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We
will bear the cost of soliciting proxies. We have engaged Georgeson Inc. to assist in soliciting proxies by personal interview, mail, telephone, facsimile or other electronic means of communication for a fee of $8,500, plus expenses. In addition,
our directors, officers and employees may solicit proxies in like manner. These persons will not receive any additional or special compensation for their solicitation services. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc52141_13"></A>DIRECTIONS TO ANNUAL MEETING </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>From Boston Logan International
Airport </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Follow the signs toward I-90 West/Ted Williams Tunnel. Take Ted Williams Tunnel to Exit 25. Keep right at the fork
to Congress Street. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>


<TR>
<TD VALIGN="top" ROWSPAN="7">


<IMG SRC="g52141pc_pg001a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="5">


<IMG SRC="g52141pc_pg001b.jpg" ALT="LOGO">
</TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Electronic Voting Instructions</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Available 24 hours a day, 7 days a week!</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Instead of mailing your proxy, you may choose one of the voting methods outlined
below to vote your proxy.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">VALIDATION DETAILS ARE LOCATED BELOW IN THE
TITLE BAR.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Proxies submitted by Internet or telephone must be received
by 1:00 a.m., Eastern Time, on December&nbsp;3,&nbsp;2015.</B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ROWSPAN="4" VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="4"><B>


<IMG SRC="g52141pc_pg001c.jpg" ALT="LOGO">
</B></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vote by Internet</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#149;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Go to <B>www.envisionreports.com/PSDV</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#149;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Or scan the QR Code with your smartphone.</FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#149;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Follow the steps outlined on the secure
website.</FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ROWSPAN="2" VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px">


<IMG SRC="g52141pc_pg001d.jpg" ALT="LOGO">
</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vote by telephone</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#149;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Call toll free 1-800-652-VOTE (8683) within the USA, US territories
&amp; Canada on a touch tone telephone.</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Using a <B><U>black ink</U></B>&nbsp;pen, mark your votes with an <B>X</B> as shown in</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1">this example. Please do not write outside the designated areas.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#149;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Follow the instructions provided by the recorded message.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g52141pc_pg001e.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT>&nbsp; IF YOU HAVE NOT VOTED VIA THE INTERNET
<U>OR</U> TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT> </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt dashed #000000">&nbsp;</P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="97%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center" BGCOLOR="#000000"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#ffffff"><B>&nbsp;A&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Proposals &#151; The Board of Directors recommends a vote <U>FOR</U> all of the nominees listed and <U>FOR</U> proposals 2 &#150; 5.</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD></TR>


<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">1.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Election of Directors:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="7"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="6"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="4"></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="5"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="4"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">+</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="4"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="5"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="4"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="6"></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="7"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Withhold</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Withhold</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Withhold</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">01&nbsp;&#150;&nbsp;David&nbsp;J.&nbsp;Mazzo</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">02&nbsp;&#150;&nbsp;Paul&nbsp;Ashton</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">03&nbsp;&#150;&nbsp;Michael Rogers</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">04&nbsp;&#150;&nbsp;Peter G. Savas</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">05&nbsp;&#150;&nbsp;Douglas Godshall</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">06&nbsp;&#150;&nbsp;James Barry</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="28%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD></TR>

<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Against</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Abstain</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">2.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Approval of stock option grant to CEO Paul Ashton.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD></TR>

<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">3.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="17"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Approval of stock option grant to the following non-executive directors:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Against</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Abstain</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Against</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Abstain</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Against</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Abstain</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">01&nbsp;&#150;&nbsp;James Barry</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">02&nbsp;&#150;&nbsp;Douglas&nbsp;Godshall</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">03&nbsp;&#150;&nbsp;Michael&nbsp;Rogers</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">04&nbsp;&#150;&nbsp;Peter G. Savas&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">05&nbsp;&#150;&nbsp;David&nbsp;J.&nbsp;Mazzo</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Against</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Abstain</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="19"><FONT STYLE="font-family:Times New Roman" SIZE="1">Approval on an advisory basis of pSivida Corp.&#146;s 2015 executive compensation</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="12"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="11"><FONT STYLE="font-family:Times New Roman" SIZE="1">Ratification of the appointment of Deloitte &amp; Touche LLP.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Against</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Abstain</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="11" VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px;page-break-before:always"></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:3%"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Important Notice Regarding
the Availability of Proxy Materials for the Annual Meeting to be Held on December&nbsp;3,&nbsp;2015: The proxy statement and the Annual Report for our fiscal year ended June&nbsp;30,&nbsp;2015 are available at <U>www.edocumentview.com/PSDV</U> for
street holders and <U>www.envisionreports.com/PSDV</U> for registered holders. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>IF VOTING BY MAIL, YOU <U>MUST</U>
COMPLETE SECTIONS A - C ON BOTH SIDES OF THIS CARD. </B></FONT></P> <P STYLE="font-size:24px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g52141pc_pg001f.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015 Annual Meeting Admission Ticket </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015 Annual Meeting of </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>pSivida Corp. Stockholders </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Thursday, December&nbsp;3, 2015, 10 a.m.
(EST) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Renaissance Boston Waterfront Hotel, </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>606 Congress Street, </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Boston, Massachusetts&nbsp;02210 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Upon arrival, please present this admission ticket </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>and photo identification at the registration desk. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>You may obtain
directions to the Annual Meeting </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>by calling our office at (617)&nbsp;972-6235 or </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>e-mailing our office at afandel@psivida.com </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:3%"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting to be Held on December&nbsp;3, 2015: The proxy statement and the Annual Report for our fiscal year ended
June&nbsp;30,&nbsp;2015 are available at <U>www.edocumentview.com/PSDV</U> for street holders and <U>www.envisionreports.com/PSDV</U> for registered holders.</B> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B></B><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT><B> IF YOU HAVE NOT VOTED VIA THE INTERNET <U>OR</U> TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED
ENVELOPE. </B><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT> <B> </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:1px;margin-top:0px;margin-bottom:2px;border-bottom:1pt dashed #000000">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD></TR>


<TR>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Proxy &#151; pSivida Corp.</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="middle"> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>+</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:4px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Notice of 2015 Annual Meeting of Stockholders </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Proxy Solicited by the Board of Directors for the Annual Meeting of Stockholders &#151; December&nbsp;3, 2015 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1">The undersigned hereby appoints David J. Mazzo and Lori Freedman, and each of them, each with the full power of substitution, as proxies to represent and vote the shares of the undersigned, with all the
powers which the undersigned would possess if personally present, at the Annual Meeting of Stockholders of pSivida Corp. to be held on Thursday, December&nbsp;3, 2015 or at any postponement or adjournment thereof. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares represented by this proxy will be voted in the manner directed by the stockholder. If no such directions are indicated, each of the Proxies
will have authority to vote FOR the election of all nominees, and FOR proposals 2, 3.1, 3.2, 3.3, 3.4, 3.5, 4 and 5. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>In his or her
discretion, each of the Proxies is authorized to vote upon such other business as may properly come before the meeting. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">(Items to be
voted appear on reverse side.) </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="97%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center" BGCOLOR="#000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#ffffff"><B>&nbsp;B&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Non-Voting Items</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Change of Address</B> &#151; Please print your new address below.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Comments</B> &#151; Please print your comments below.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Meeting&nbsp;Attendance</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2px solid #000000; BORDER-TOP:2px solid #000000; BORDER-BOTTOM:2px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:2px solid #000000; BORDER-RIGHT:2px solid #000000; BORDER-BOTTOM:2px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2px solid #000000; BORDER-TOP:2px solid #000000; BORDER-BOTTOM:2px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:2px solid #000000; BORDER-RIGHT:2px solid #000000; BORDER-BOTTOM:2px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Mark the box to the right if you plan to attend the Annual Meeting.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="97%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center" BGCOLOR="#000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#ffffff"><B>&nbsp;C&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Authorized Signatures &#151; This section must be completed for your vote to be counted. &#151; Date and Sign Below</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:4px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1">Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor,
administrator, corporate officer, trustee, guardian or custodian, please give full title. </FONT></P> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Date (mm/dd/yyyy) &#151; Please print date below.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Signature 1 &#151; Please keep signature within the&nbsp;box.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Signature 2 &#151; Please keep signature within the&nbsp;box.</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2px solid #000000; BORDER-TOP:2px solid #000000; BORDER-BOTTOM:2px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-TOP:2px solid #000000; BORDER-RIGHT:2px solid #000000; BORDER-BOTTOM:2px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="6">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2px solid #000000; BORDER-TOP:2px solid #000000; BORDER-BOTTOM:2px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:2px solid #000000; BORDER-RIGHT:2px solid #000000; BORDER-BOTTOM:2px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2px solid #000000; BORDER-TOP:2px solid #000000; BORDER-BOTTOM:2px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:2px solid #000000; BORDER-RIGHT:2px solid #000000; BORDER-BOTTOM:2px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="4"><FONT STYLE="FONT-FAMILY:'WINGDINGS 2'">&#162;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>IF VOTING BY MAIL, YOU <U>MUST</U> COMPLETE SECTIONS A - C ON BOTH SIDES OF THIS CARD.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="5">+</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g52141g45p01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52141g45p01.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0GT4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !M    !@              0@   'P    & &< -  U
M '  ,  Q     0                         !              !\
M0@                                             X0DE-!!$
M  $! #A"24T$%       !     (X0DE-! P     !U@    !    <    #P
M  %0  !.P   !SP &  !_]C_X  02D9)1@ ! @$ 2 !(  #_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  \ ' # 2(  A$! Q$!_]T !  '_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "
M4 !H &\ = !O ', : !O '  (  V "X ,     $ .$))300&       '  @
M 0 ! 0#_[@ .061O8F4 9$     !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,#
M 0$! 0$! 0$! 0$" @$" @,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P/_P  1" !" 'P# 1$  A$! Q$!_]T !  0
M_\0 <@ !  ,  P$!              @)"@0%!P8" 0$
M    $   !@,!   $ P0+ 0     " P0%!@<  0@)$1(3%!46."$W6 HC0U5E
M%V<8J-@9&CD1 0                    #_V@ , P$  A$#$0 _ -_& P&
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M=#3D!9"-W?3W4*5QESN/Z^U[TF#]$>@ .-5!;Q@,!@,!@,!@,#__T=_& P&
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M[]ZA@*[:E0;(8:0\)PH.:(?)60:/[)0)*<\?TII@%"Y&9]'86W</><_'WG9
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'# 8# 8'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g52141g67j48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52141g67j48.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0J84&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !M    !@              70   +0    & &< -@ W
M &H -  X     0                         !              "T
M70                                             X0DE-!!$
M  $! #A"24T$%       !     (X0DE-! P     !_L    !    <    #H
M  %0  !,(   !]\ &  !_]C_X  02D9)1@ ! @$ 2 !(  #_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  Z ' # 2(  A$! Q$!_]T !  '_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
M @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1
M Q$ /P#U58?6OK1CX%GV3$9]LSG':*FR6M<?HM?MW.=9_P !7^D_XM-]:NN.
MZ;BC'QW;<O)!VN_T;!].[^M^95_ZC0/JGT2O$QAU/*'ZS>-U6[4LK?K_ -OW
M_3M=_P!;_P!(DIGC='ZWU"+^M9UE+7<86*[T@!^[;;5[O[.__KZTJ>A=&H$,
MPZB>[K&BQQ^-EV^S_I*^DDIA7354-M3&UM_=: !]S5-)))2DDDDE*22224I)
M)))2DDDDE/\ _]#6R >M?6LU/]U;K_2CMZ-&[>W_ *YZ5G_;J[6U_J9M6./H
ML!M>/$CVU_\ 2]ZX[ZNQ_P ZC/[V3'QDKJF/V]8>#^<W:/\ -:__ +ZDIT4T
M@=TZP.J8F+F?67!HRF[ZG8MQ-9,!Y#ZB&/'^$9_A/3_D)*=X.!X(*!;DV^L:
M**_4>UH<]SCM:)^CV<L7ZP](Z5A=(R,W$QZ\7*Q@+*+J@*W->"-GN9M^G]#8
MM4L%N4[T['49#6-]2 "T@SMT?/T4E)/4Z@-?1K/D+#/XL3UY+KL=MU3)+G!K
MF.,1KML_S5'[/F?]RS_F-0'7/NPVNL@N;>UA<.#ML#=R2G0!!X3.) ,:N_-$
MQ)\%CD?LCK@<T1@]8=#QV9F >U__ *&U-V_\?5_PBA@C]JYN1UE^N-0VS&Z:
M#P6CVY66/^/L;Z5;O]!5_P (DIUL*W)MQ*K<NH8^0]H-M(>+ QW=OJMAK_ZR
M;/R_LN#D930+#CU/M#)B=C2_;N]VWA<K@4UY.!]5\#(&[#NIL=;3)#7NKK:Z
MEKX^GMW/=Z:T^N="Z)3TC,OKQ:L>RJFQ]=M8%;@X-.WWMCZ7T=GYZ2G9Q;_7
MQ:<@C9ZK&O+9F-P#HE%!!X,KEKZF9F5T[%;B-SKJ,!EWI9%OIX[6O+:_4]-M
M5[K<C]%L_D,0\W!MPCBY(Z;C8%C<K':S(Q+27#?;76^NVLTX_J575N=7^>DI
M_]'1;:>D_6=UEGM;1E.WD_Z*TN]__;%_J+K^IL?5DUY#.\0?Y3?_ "35D?73
MI!<!U6ELAK=F6!^X/YN[_K?T+?\ @_\ BD7ZL]6IZAACI.8[]9I;%+CR]C?H
M.:?]-1^?_P!N?Z1%3T>/>R^H6,X/([@]VE9O4>BMZAU7'OR&-LPZJ+&.!<YK
MQ8YU;JGU[-KF[6L?[_40XRNG6S^:>_YCO_(O5ZGJF,\>\FIW@[C_ #@@I WZ
MN='%C+'4.L=60Y@MMML:"/HN].ZQ]?M_JJ]=BX]Y#K6;G-T#M08_K-A,<S$
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M '0 ;P!S &@ ;P!P    $P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\
M<  @ #8 +@ P     0 X0DE-! 8       < "  !  $! /_N  Y!9&]B90!D
M0     '_VP"$  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$" @(" @(" @(" @,# P,# P,# P,! 0$! 0$! 0$! 0(" 0("
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# __  !$( %T M ,!$0 "$0$#$0'_W0 $ !?_Q "7  $  00# 0$
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M;44@S)O'KXRM )$1SU,;K,_C:SMR=E55X)5:R4: : : : : : : : : : :
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MW+.8GFQG*TB87CKTK*7;Z^1<RH XAK42*OW!57#5R>)"-7;66TOJC4-\E\P
M#&"*/&"*/' -@0  -@@A$-J,&(0AHU@QC8B(UJ(B(B;)K!3ET T T T T T
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g52141g86w55.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52141g86w55.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0M>4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !M    !@              :0   &     & &< .  V
M '< -0 U     0                         !              !@
M:0                                             X0DE-!!$
M  $! #A"24T$%       !     (X0DE-! P     ",$    !    8    &D
M  $@  !V(   "*4 &  !_]C_X  02D9)1@ ! @$ 2 !(  #_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" !I & # 2(  A$! Q$!_]T !  &_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M9]7ZRW]7P:6,R+)B6NS<JT>U^_\ P6-^CV+0^IG6<CK7U<Q,_*C[40ZO(($
MV5.=2^P >W])LWJU]8.JT]'Z+F=2N,-QZG.:)VESS[*JVN_>LL<QBK?5;I_[
M#^J^#B9;Q6['I#\EUA #;'DWWAS_ */LML>S<DIV20!)X7/8OUYZ-E_6(="Q
M]]CG![6Y8'Z!UU8WV8M5G^$L;6L^W)ZC]=,E^)@N?A_5>LEF3G-]MN81H^C#
M=^9B?Z2__"(WUHZ7^R^G]*SNCX@]'H&2V]^/2/TGV7:^G+;0/\)9Z;][]_\
M.?OI*>L253IG5>G]6PV9O3[V9%%@!#F&8G\Q[?I5V-_.K>K:2G__TO54/(OK
MQL>W(M,5TL=8\\PUHWN_Z(1%@?7OJ#.G_5'JE[G%I?0ZAA'.Z[]7;'_;B2G
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M $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0 ;P!B &4
M( !0 &@ ;P!T &\ <P!H &\ <  @ #8 +@ P     0 X0DE-! 8       <
M"  !  $! /_N  Y!9&]B90!D0     '_VP"$  $! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$" @(" @(" @(" @,# P,# P,#
M P,! 0$! 0$! 0$! 0(" 0(" P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# __  !$( &D 8 ,!$0 "$0$#$0'_W0 $
M  S_Q !I  $  @,! 0              "0H%!P@& @$!
M     !    8# 0 " @$"!P$      @,$!08'  $("1$3$A05(0HB(R0V%W>W
M&1$!                     /_:  P# 0 "$0,1 #\ O\8# 8# 8'P::626
M8<<8 HDH S3331A+++++#L0S#!BWH(  #K>][WO6M:U@5;[(ZSOSU&]/>.J+
MY(L!S@/GM1=KS>_;6N.%38V-2'K5;R4^0E(^EP@+.YH7B8<J)K;L!DA^W,C9
MC)*'@;D:4)42TEC %I/ 8# 8# __T+_& P& P&! 3T)=3]ZQVS8O G,<D=&'
MB*M'9;$_1KL2,+ IVJ7E-Q0]S#B"AY.$9"<^4RE">6FG4F1GFE1YF./2EZ$I
M/UK88?Q%A,2MN6]4=ZP:$M,%H&4R-NXL\]8O'RER:*M'!O)+@YQB,RV(('#1
M:I W77:ZA\?E03B]'FGD ,&(SY"8(+!V P& P&!__]&_Q@,!@,"#?T1Z8N;H
M"_(UY+<*31WAEVV SM\M[1Z0AZH!3CQ9RV[$!-6J6ES$VN!+3?ETM)VVZ(:
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MB+Q:-LB,EN9H_'(^WIVED9&AO3 +3H6QJ;$A1"<DL(0%%%A"'6M:U@9[ 8#
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B_]2[U2?^Z>C_ /O@_P#\FJC W]@,!@,!@,!@,!@,!@?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g52141mazzo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52141mazzo.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0EH4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !K    !@              *@   )$    % &T 80!Z
M 'H ;P    $                          0              D0   "H
M                                            .$))3001       !
M 0 X0DE-!!0       0    ".$))300,      ;.     0   '     @   !
M4   *@    :R !@  ?_8_^  $$I&248  0(! $@ 2   _^X #D%D;V)E &2
M     ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04
M#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,_\  $0@ ( !P P$B  (1 0,1 ?_=  0 !__$ 3\   $% 0$! 0$!
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M&^]T?1]2UTVV?VWJ^DDI_]DX0DE-!"$      %4    ! 0    \ 00!D &\
M8@!E "  4 !H &\ = !O ', : !O '     3 $$ 9 !O &( 90 @ %  : !O
M '0 ;P!S &@ ;P!P "  -@ N #     ! #A"24T$!@      !P (  $  0$
M_^X #D%D;V)E &1      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$!
M 0$! 0$! @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,#_\  $0@ *@"1 P$1  (1 0,1 ?_=  0 $__$ &@
M 0 " @(#               ("0<*!08" P0! 0                     0
M   & @(" @(" P$       (#! 4&!P$(  D1$A,5% HA(A8F%Q@1 0
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M_6=^PI#EZQ93O?HVRI.!.-.U(K>TTJ(L04PUH0EIW(XYJLU"J6IVTL(LK\)
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M[/,U-[5]XJ8I%ZAS%N-M1LWL]I;4;HT$1MVED<#$5.*V4IFDYN3-:)#/I4C
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8. X#@. X#@. X#@. X#@. X#@. X'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g52141pc_pg001a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52141pc_pg001a.jpg
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M Q$!_\0 Y0 !   & P$               (#!@<("0$$!0H! 0 !! ,!
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M+YU_,+ZG]_VG:E-&^(H2*#&2D?W>/=8EN96SW!ZJH9L=I4D^TQX^,4'G_.N
M5$H=Q3%+SET,Y=2HM<'<%D)X>_2JK5<!EM7RB[M@;'D3IRB=0D'3B1A(-PN7
MY@%K(LNI\Q/2Y#'_ *0JA_@%XXX-URCW T %**2W11,;'0[%"+B8]C%QC-,B
M+-A&M6[)@V2( %*DW;-DTD$B  = *' !EM%Z7 ?8'L]GV>G\&$7/ ?9]O\?K
M_#A$XX],(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PB812CB;D *(\]HB4 ]O' B ^S[./TX1?.;]6?S
M9>RLV_\ %_6\NJA!PXIFVK+L%S@I)2(B!TJD1PB("+-L42BX H_TBG!1Y#)M
M';VHLDOI6>$K+6=-8^0NQX<BNP[FR35IT<_1+W4^JN2@"+X&ZQ1*C+2Z?:<Q
M@X%-'@"^HX<YQTJ50- X"BW.)&35 IDS)J)B(]IB"!BB)>@]0$0$0,&055V<
M(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3"+'ORHW(UT%H;8^TEE4R.Z]7W184B@\ M//R_)
MQ"9>@]QBNE0.!?Y79QE1J47R8^'>II'RE\K:9 6<[F4:RUB>7R_N%C"HHXC&
M#@99^*JIQ'O^:6$$^##Z=,NNH!HK8+N:E=%]>FR;,G48&$K4 1)M*V-VRJ]?
M;(@!"LFW)&JBR90Y[$F+0."^P!XRT 3J%<5S(EBE&L&D>B!NQF@F@!SCR=04
MP[#*G'VG5, F$?;SE*HO2PB81,(N!$  1$> #J(_9QUZ\] #"*@)+:- BG)F
MC^WPB#A,P_$1^<2.H00-Q\,Y2&,)3!P//.5H473)N/62AP(%RABB(\ )W($+
MR/VF,' !E*(JXC9B,F&Q'D3(LY%H<>TCAHNFX2-[1#O2$WO_ '#QA%#&S<7+
M*/48Z0:OE8UQ\I()MS@=1FYX$WP7! $12/VAZ#A%ZV$7 B >OM_N]G7"*@XS
M9-$F[I/:[B;5"O[O5&+61L56:ODE9B%8OS%(T=R#0HBJ@@N)R]AAX#KA%7G(
M?:'\(81>5,3<97HB0G9M^UC(B*9K/Y*1>*%19LF;<@J+NG"IA $TDR (C]@!
MA%T*K;JW>*_&VJGS<?8Z[+-_F8V8BG!7#!ZCW=OQ$%R<E, B AA%4@>@=>>@
M=?M^_P#7A%SA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$
M3"+3E]:J<?,/&RHPS58Z;6>V(R+()@(_#71CV2RZ9%2@ ]X%55 P?8(<Y)J+
M$WZ'],;OK]NN^KI)J.(:OPE9:J=@C\ THY&07,F8P#V'603X'CU#)..E#Q5.
M4 U6WFW2PS'DQ3H@Z@"SKZ9")I<E$I'2K19\J(EY'@Z@)D]<JT4C<50DU "S
M%#T_6/\ $/&61W]JDH3F[0#[1'@./41'T .0$,JBUX[%\_HVE;SO'CY#:=OV
MP=@UN-AWU>C*B5!V:SGDD4W+L5C*)))0C&+;G$5'"IS%$0X .O2M"!4HCWR\
M\C(UJN^<>#6T#MVJ7QEP9VNOO'7PB#RL"+1)N"JZP$ZD(7D3B/LRB*[>N?(^
MK^26B[A=];$FHV4BVLK!SE=EVAF-DJ]D9)"#N)?MR\@#DA0,)1(/IUX#"*?J
M%MI@:5$+OAK"\XLV$9M2>,V/("]!13XP+E>G,<I@./&2YG(KFJM-(K)"F=*@
M"4X"00+^4D-P(" @4Y#E,41].0'!+J:\$70UO0&]2L]JF*_*QZM1GQ;C'Q$>
MX,\1CW*8@ F3,515$A1'GG@<BBM[:-N,M9T/=.P:7JY]8G]"E3R%E@XJ1(A)
MV4C=,QY&4;*JHN""NS:$,?X7  (![,(KO::VU6=Y:UJ&TJ8Y!: MT4WDD$S'
M(HX8+&*4CR,>%)Q\)ZQ=@=,X>G)>>.!#"*UF_P#R>BM)VK4VO6-8D+YL7;UE
M1A*[4X9TDV<MHTJ@!)65^LL10J,3&D 1,;CWA*( .$5N=6WG4DIYI^0M+K^K
M&]>VS7:%5I&\[1!^HH:WQ#IRS(QBC,S>XW)'*&*8#@4!'MZ^W*EIY:]I314H
MY\^G=KN5JJN@O'S8^[H^D3+JN6.XQ"L=!5<DXR.<CIC&OGX+@^^")/Q>X'7[
M.N'"A16C\BO,#9S?3.RXK9GB5M*@UJP4FP0RUP)(Q-F80CI^P409JS2$<4JS
M6.,NH!3+<B4H^S#14T1>UXZ>0%,\9/IS:9V5=D)*0CVL-&0T=$02)%Y"9F96
M45:1K!B144D2F66. =W< =?;Z91%<=AY@^1$HS;R+3P=V@#5VB5PW*ZMD"U=
MG04]Y(YVJJ!54Q,D(&$HAR'/&$5:Z3\TXW9>SU])7[6-WTIM8T.ZGXBMW))L
MJSGX=H<I'#J&EFYBIO3H"(]Q>P/3*D: HLW@] ]OW^O]X,HBYPB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$6EGZVX\:%UI_^XQN/T_EGM#T
M$.N7&=R*T'T,WJ(,O(2+%0OS(R=/?%(/'/RY(]=L<_VB *#Q]V2E %#VJ+36
MJSPNDR-<\DU)5V(E2;6&%.LL!> *T7:MT#'Z]."H'$!_1SZX!^KHA]H+8F4P
M'*!@Z@8 $!Z" @( (" AZ@(#EE20_I[..0 >?8 ]!']6$6HK5$[6H;ZJGDJU
MFI*+CI*9U;448$L@NV;+.UFY&!W:#!5P<G^<&1'D2E'N,7G)FI8$6V-63C$$
MQ<K23%%$A3**+*O6Z:*:0>^=0YSK 0A"@'4>> X^S((M3?@=8DV\]YV[ K2:
M<_3U=SRCV 19>Y'2:C-F8KT&:P%,BH4P@(&$O(819Z5JK:@V/ 1UJ7J]=;.9
M9$'#Q))5%%PW<B/"R*YDU$Q,8IPZ] ZCE14:HO:_J7TX "/Y!$"  (_^W&X
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M7/?UXZ<^Z(AR'( 81#G@>#<=/LZX11X1,(I0J#R  7GD>!$1$ #CGNY]T>
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MUL?&NO1)I*J/E9BI>$WC4TVM%UK99T5"$.XUL*E_3,G) )DSHI%$?=)W"19
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M-51XY$HCQQP!C<\  AQW"  /</'/3(DO:VD8;7TD]Q_@^^HMA:US9=3.T=O
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M:-H%FV*,SJNS.E7%6+\$2"F16P,Y!)(O  8!:F#GD!S/I,%C3>OG<UH8^*@
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M^0O0I0XXX .GV=/3-8:=G!?.#CJ>*YPB81,(J;GCLT(Z77DP3&-39.57P+$
MZ(L$FIS/"K%$/>2,@4_(>T,I'YLDC61NHX2BGS!3L[:YGO6167,+QTC3&X=D
MG!M/4XA8,5+=7A]93.',7 L8M$*H6=9.YJDR$.E8ZMKHCA^W<UURZ;D)-$KA
M5%#H$2,)P*;DH" YD%W89EDS6F2K@=0"#0/T'#U+T-GNGW7[$NM["\O))?[8
MYI9#>M?Y%S?EK'^<R-Q\H7/A!+Z D:ZKWF.[O&MU26ED=5F6@*1K=6,M58D)
MZAR\,T92$TY,$6ZJ*CMNF=Q-2;AZ/PTT!$Q_B=0$!RK\=E(IG,BD N9*!]'
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M<U&^01TK*:,=3U:>7K1*TC61C KL#&VYG4)&+!=^W2:69X+!5*43-_2 !7(
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M:7[?7"H6M.A"A%,O7@A?U% .@]!#D!Y],K4]BE0$@GL4M,@]_<9/@P<!W<
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MU<UU8&53\=QVG%BH9S(<N#6,C=7X+I00 #MA-[@<#QUS<6Q+<3X@T8ROG/\
M:EY/S?2OK+\$F*Q-[TAG?=X[$W<OVM-X[G-ML)J<L=/J"X5;W/IXM>Y:V?W\
ML'^LO>W^Q8K_ ,BS-?<9?S8O[TW\J]B_NYM__)MN_P#50_E+:Q])F>DYO<&Q
M22%IV#82DI+(X-K=HD=4M$SFD#E!TWE/@(DD%S<<&1 1X#KFMNH$;V6<$4L8
M8*_1G;)^!>%/CPP^*L-D8?W:RQ=N1DWFMIF?M0N^J'T XF/UFB^A0OX0_0'[
M,UC2F@7S 7.$3")A%3%@@HZPL9.$E&_S,;,,'$?)MP.8AG#)ZB9NX3[BF Y0
M%,>![>!X,.2BE="XR]K/$U7[&\N,?DX<G9O:R]MWM<QU-00:M'=2NNO:%B?;
MZWXG6:MV2"L1J6:MZ 8JU>U V>%8&H;208QWQ8N7<LOAN$049)-C !Q$>\I3
M?BYSNK=^:@D\V(UENQ5@_#]^JW)ALUUTPF8M[S#,R?VIN>5MS;.+/-;?.9)(
M ^$.- YCO,:=/9/<K3,HGP)?Z]NZZ-FK<A31"LDN4_(V687F6ORKE,]03"3>
MK#+-T2NBE%H"/!#' .,YOFYZUN(X@"UXYCR@ MJ10GUGM6;OR/Q1-WSC8X;2
M^CW(YMS[K'#;PM@-6$7(?"T>7)S1U\POU'%9 Z#9:!2@+.II*2BYMK*2I?WK
MD$Y5W,SCN4^5!-)"PNY0QY #D:<E0(?M(!3#V^HYUE\W)&>(WC'L:UO,. ;H
M*#0:=BU/U.N.J+;ZV=U-CELWPP<UK'Y+8XVQ5!)@;'X'?6'Q$:U KH I^H];
MZ%IUZNC+7*$=^_<,U9(V-@$NYF)*HQ,\96591#=L[76/!1\@L<R_RQ..XXB/
MIQEF\N<E)91/>X>22:4TX'[]%3>6[>J&YMM6,N\Q+'@)9"Z$B)L3+J2$!AE<
M6 "61C0&DFN@&JR=:)@F"@ /(]Q>>0X-^'IT#T*/L]N<%S^<Z^UVK6HJ=101
M]@#0VG?PXZKMY%53")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(M,7G9=]WUO=+*/UY>]@5N"5IL0X4CJM+6)C%F>G<NO
MF7'PXG4EW;"Z4(0I1'YPHC_]6'MV1L_'XJZQ1FOH89KCS3Q /X9HE[V^&;:_
M3S+=.I;[=.+Q=]E69%_+)<,@=+R4;Q,F4M#R>CR3^D>"PP_K;\JO];>YO_B.
MZ_\ ]<\RO[+V_P#LT/S1?XE>C?W$Z*_Y!@O[O:?_ .\L\_ *Y;@L^PKFWV1=
M;K:&"%8:K,FEHDIU\W;N =F*59(LMK"C)E<G)^(2+*C_ +P,PC>EAC+>W@]T
MBABU[ /Q3RKRW\4FV=@8C;.-N=GXNQQ]P^]>)'6[(6ND'EC1_E9"\-/6V/UE
M;> ] _0'[/OS UX?' 4X+G"JF$3"*D;6\F&$+/.X)C^:3+:,=N(B.$Z:)7T@
MDV.9JQ,NH/:F#I?M*)AY[0-Z9.)D3[B,3D,MJU<?SERL;;VEYE;>UO9S;6DD
M\;99.6O)$'5>[A^;737@M0K[Q:\B:G5K$[:.(C8,KN&@237:D#&,FL)(L[N%
MM:WF'E'DJ\E'3:PN42NG<:"HD0Y3(F ].,SDYFPO)8F2-$,4#O"[OCY>4_\
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MX^H E1[(VQ4=30;"?O4L6%C).S5^GLW)R*K_ !)^R2+>+B6@@D4PE*\>N2E
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MY_H7F9^[V_[9)_03_P!8O5OV%L__ )D/_#-R?XQ;,OI?S=H?[2O:,WK=O34
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MYNJJ[2U/L.BPB,LWFM-^2OCS7+0+UND@V<2,S9*Y8FAHM9-=45VH,Y$I3B8
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M?OC=B;"XM+0\C.:*VNZ^\1U+=1)4UK4M[*)-^-VG; KL!66IZ;D^SK35;I>
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MM>*[,CXSZ9F$YD'],2<C.;.A=P2O>\>%%UL.OJLE(B?$P+ )3LC-$^T@<)F
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6#T#*'BI+G*(F$3")A$PB81,(F$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g52141pc_pg001b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52141pc_pg001b.jpg
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M Q$!_\0 Q0   00" P$               0%!@<#" $""0H!  $% 0$! 0
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MPA69SMJ.C&J\4#CQ\ZHO&7W)/*^QR4HUE;375TFU;4D403K,>D8'(6V9B2F
M0)U &3,@#OL&X;^NM6\Z*PD;08HBI>A]9X; ?/SKTCJ_[1NQV*LH9;*RNV/?
M=ACC\P\^DVT,B?\ 3<XJ/-*DN<?N(^4='C\8N8"T5]!2S8K;6B6%6N,'!59<
M^1T:\=9,#$_*3^EG$O$.G+KMJ+$='8"X?.+EKCR[@M"..C>5N3CKK63VW^U'
MLKU!?9F'*6=S)%9YIUO&EP]J1"P,^TH=3S!N4Z^'"O;[QIO5CR1ABGW*U.47
MD[,H.E'J[=NFU1.*;I5(O!!, *0.! ]->5YNUALLC);V^D343C7YO]X>FL5T
MEW"R& PC#%BX'M#&EQ>0"T'5QU))_*K^UE5YG1HHHT44:**-%%&BBC111HHH
MT44:**\=O. BQO*K%!DT'!RACRR;J)-U54RCV9 -C&(4Q"F'X;B CKT;IE!T
M]<$\.:/+V5]\_;BZ,=D<ZKF";ZM;[6N("J6>?AYUXI8M:.P6G.;"0 1Q_ !U
M8.RCO]0EQV_X0;CU_P =>B.>#%'J =YXI[/;7Z(=9S6I%L&S0N(R<RAKF(#L
MB54/!=!4]STW=]G$8$92 B3$],*8"L71]C!D(YN!@*B.P[>H#\-4L:?U+EI0
M R.0Z:^GWUR_:Z:-LV?<Y\"NSEYIS&A4L1X$\/;4_P"PZ#&WD$ M'Q>6/FX
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M0.5@Z%(Q1Q5'E,)3@D)-@$-N@[;_ -=%EM&#MF%P5MLY>'C(?;5+HFXC_P"
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M]C 81ZZ/ZZ:H#5\:N/QNJ,[BK)'C5DVO9GSG)SM:^Z_E3Q'K\?9\B6&<KS3
M3".F%24-Y#O%#M91,'"15 =K@94#AT-MHXTKB"=$1*IW+-LR%=O&[#,W.Y^C
M;(C7<S^:[R3P#EK,%MPX.1HBN7V4!G8:1E*.[+<;Q2V3<$XJ+<J<3CMQ*.BD
M  \*>O,7.A[E!^-'D0A>+C.8_K7B!CNQJ^+>2\YVC$/DC02P]C2;J92Q38VJ
M:$/EZ[V,R()=A4JJBR&PB3YM%*@1*V6\N_(W,BLS]PB9HU_R]2L?SE5^W*C=
MUP>20W/#N#\BQ+(N3I]D@@F)H2>6C5A+*.T0 Y.9E!VT4S:!H[C6N^2KFUI]
M$\I\+>&ODGF*Y>$\9Y">%49C[*[*_P _8I&L9(R#.M&N3J72<@N1.]D(]=BM
MW7*0'.FBNH(#MHI[2%4^5>ZWVI*TXPMY=_<H\:*[=K_9\4XPO.))ZEQ.0+1*
M6Z0@)*\4L9:T"SEY<RCGV\G);K"F!N!3#T -%-/P-'CK3WG!<I/OT^$*(&$#
M*>&WD7\O;$Q3%^KQ6_(X$$H"'$-NNX#Z:*8IV[:\8+WD]]:Y>1QOY'9LR-2/
M#FX_=P\C:9GF^-;E,UA*(A(&HM'V/Z!)7!EVW57ICB6 3% ABI&4 "[]=%/.
MI]J527F59+HLAX8K_;HRSEG,]2@,)>4,8[RO?UI!'+[KQ^K=J;_R*GCJ==()
MO9)W&02"K:$?&W47;E Y3"/712L/%4X4Z^965']VS92V&-\W&Q[@Z@^&F";]
MX4W>^YLM5%;,K=+R;,++:TD&95ULO7Y*5*+.4CW'<.01. E !T4C$_&O5#[9
M-$H5:^[YYZ2UONDBIY!6+$& +.M"+V>2)&W%&R4AHZN=QB*ZZ[:<A%?54R&0
M,)1%F"@E  WT4T_#^-?344! H (\O7KOO\?QT4VNVBBC111HHHT44:**-%%&
MBBC111HHHT44:**-%%&BBHD-$I(W(N1#56 &^%B!KY+>:,:#8B08J=XT226%
M(7I(\5?F%(#@03=1#1140LV#<,7(EU1M6*Z%8T<E-8]ED LU5XE^2Z-(KK&(
M6,'+53ZN$<(!V>^!Q3#^T0T+I2ZUQ#8%PC7"Q1*_B7'<*2$E6<[#DB:E!QY(
MR:CVH,64LR*U9I%;2#5H';(L4 4 G3?2 @E!2'VTY(X>Q2W!GVL=4M+V%L<W
MMCVZ]&$]I<WH&*ZM+?9M^7/N"J"!W0;+#N/S:6BHE:O&+QTO5:94RY8/Q;9:
MI&3KJSQL!-4N!D(MC87K@SM[--&J[(R;:0>.C"=90@ 94P[FWT4NXJJZTKNG
MCEX_Y%<4UY?,,XPMSK'9F_[&7GZ9 22E3(S[?M$8(SEB?V#9J*91(DGLF40#
M8H#H.FIH!-2YUC#&[U>UNGE$J3US>HMM!W19S Q:Y[5#LVPM6<78#*MS?5&+
M5L82))+<B$+T* !I-PI*B=<\=\!U.F-,;U?#N-H"A1TTA8VE/B:?",J\WL#9
M<';:;)%H,B-?JC=QL<C@2BH4P=!#2;Q2GV\:L*)IU1@INP62$K<'$V&U':*6
M::81S1K)SQX]$6[$\J\13(N_,T0^1,5##P+T#IIU)75S2J>]M,7>GE:@G5SA
M(YY$1%J7C6JD]&Q,@8#/HYC)G2%XV9NS$ 5$RG AQ#J Z**A5BP%@^VU6S4>
MU8EQY/T^YS2UDME9EZI#/X6PV%<Q#+3DK'N&AV[R65,D BX.451V#YM%(H%.
MT;B#%$.%;"+QU28PM/@'54JB;&MQ+4E=K3]'L/H*((BU(1C%/40XJHI@4B@=
M# .BE45$)CQ?\<; A1VT]@W%<PVQD\5?X];R5(@'B-,=++F=**UU)PP4)%"=
MR<5!*D!2\_FVWZZ3<.%"^535/$^,4,A&RRWH511R@>#"M'OJ4$P2M1Z^00,6
M&4FDT0?GCB\>B0G$@;= TM%6$!BB #N'4-](2!QHKGD7\0TFYM%&X?CHW"BC
M</Q#_3I5%'LHY%]-PW#H.EHHW#\0TW<VBN=P_'3J*XY /0!#?_'11[:YT44:
M**-%%&BBC111HHJDKYY 8KQO;8VD6^Q?3;-+QCB78, :.%C+L&Y53*K HF04
MR@0$#=!'?IK1M<1?WUNZYMF+$TH3IQKT+IKM;UMU=A)NH\#:<[#P2B)[][0C
MW( $.NJC\ZHV,^X7XHS)UDX_))5CM8]K*+@$1(  ,GAE2-U0W0ZBH9 ^P?#;
M6G_*6> #G0G:2@U&J>%>BW7VI]\[.-DEUB',:^5\866/5[4W#CX**6V#SZ\6
MZP$4>:R'[0LU$QTU'&")?J>XCI61-%,5PX(B).\^#AL/4/7TTV/I;.2$M9$K
MFN(.HX@*GX54Q?VP]Z<RZ=F/Q+I/EIGQ/(EC"/C9S'MU/[+-?ZJ=%?.'QK2C
M;%*'O8^RJ<>WDYU<(M^'L6+AV@Q26$.UN?FY<$+L7<>NF?ROF=[6\H[G%!J-
M2BI^556_;?W?-U:VC,63<7LQBA',9ZGAI>6C7B&@E338S\^_%N015<-,B]U)
M&25B#B$2_P#E?I*&341V[/42G+MOIXZ5SI*"+5%11PJ]<_:UWKM'MBFQ3A(Z
M+F <V/X"%!X^59Y;SQ\8H&TOJ9)W\&]BC9)S$NV 13\XHOV3-H_<(=P$A()B
M-7J9MPZ?-IL?2^;FA$[(EB<%!4:ZHO\ 0:@QWVS=YLIA(^H+3%%V+DB;(U_,
M9JQSG,:Y%75S'#STI0_\Z/&B-@&5H>7WLPK^>5K;1Y],?&!291B3S:C;M@D)
MBB6-(*@B(;?#UT@Z7S1E,/*_4#=R*."HO]E-M_MK[QW>6?@X<479&.W$[F\Q
MFD1DY(<J\#(=M**UYN>.%M>0D= 7OWSNQI=Z*2",>IBZ3!%1P)Q,=( )^4B8
M>NWII9>F,U"QTLD:1MXE04J',_;AW?Z?M;B\R>++(;8I(>8P[5(:A0^9 J.1
M7W"?%"9.X)'9'!<S=@G)+A])D"\6:CIPS*KU1^+AFH&W]-/?TGGF('PE?>*U
M;[[5^^%@&OO,0YH<\QC]2/X@&N30\=K@?QIPL/GKXP54849W(7LOW%74[1$@
M,6_/[J$4G KA'@<4?D_YO^5Q'8?CIL?2F;DWF.(D1OV.U&CB-R?E53#_ &Q]
MZ,]\P,=B"\V=T;>7]2,;91%SRS4Z_I>K3PTIS-YN^-R<9;I<UZVCZ/"&LEE7
M&,??\OAR.FC(SKCVA%4 </DR[%W'YM([I;-[HXS%ZI'!K4(U<BIQ\@:J'[<N
M[OS=A8,Q9=<9*Y$%N!(S]20M<[:-=-&..OE33'^?7BW(HN%V>0^\DVDE(E<1
MB9 .#Y,J9S(" H]1 JQ1W].NE/2V<T')XA>(X5H7/VO=Z;1XAGQ)#S&)0.9'
MJPDZ\?,&LLMYZ>,$);9&C2F0"M;-%2@0S^/&*D#"A(FBDYD$.X"(IF$8Y8JF
MX#MUVTD72N=EA;.R-8G-W J-0NU?STJ.P^V/O3D<%#U+:X@NQ%Q#S62<R-#&
M)#%N15_B MX4IE?.KQGA8!I99"^"C#/;(2HMG013\PFGE(Y66(RX ER 3,43
M'Y>G3;2LZ5SCYC"V/]1K-Q"CX51?SJ&S^VOO%?Y9^&M<479".S-TYO,8"(0\
M1EZKPWD!.-**IYO>-]T<5QM6[T,BXMJ)5H,@1CY,'B8I+K ("=(H)#VVQQZ_
MAIL_3.:@8Y\T6UL?Q:@IJ!^-0YO[<N[O3L%W=93%F..R<DRR,.PJ!JA\W :>
M=1: ^XCXFV95=*'R2+I1!B:15*,1(D C0DDXBA5V.B ='[4Y-O4>.^K$O1W4
M,&LL* N0:CBBI^1K:R/VH]\\4QK[_#NC8Z38#S(RKMC9$X_N.:?QI=://[Q:
MIZ< O/Y$!BE9X EFA#?29!3W<,>9+7RN_D1'M[RP]OB/S?'20=)YVXW"*'=L
M?M=J-' ;D/X:^55</]KG>WJ"6ZAQ6(=(^RNOEY4EC"2\KGENI\(_4OX4].?-
M_P ;6L99YE6]<6%.@U+%8%@C'WZ&(1<HLU'7'M<E>*[@@;!UZZ@;TSFR]C.7
MZI'[6ZC4HJ?D%JG']MW=^6\L[&+%DW60N!;PCFL5\I:7AO'16M)7AI3+#_<
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M "PP;] V (61^.HLJ7&QN4!V@!?S%8_=Q1@>H '*3(%'_C1UK?B@H@\L [
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MRG.Y./E.?:.9RREL9XPD<U.@W5+66];!NFH8W(Q!3;]WK_O#IEOUS/#9,M#
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M #$\ B-6E6D+NW@[-@\7;D!T)6D0^06'O?&CBWF'.Y+6S6P>)U!2"%*F"QE
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M'+N*)) .XB ;:D$<Q89-IY;2A/OJQ'CLA+92Y**&5V/A<ULD@:=K'.^%KBB
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MA,9*8FEB&X87%'%8BT?#J-5]NM0V79KM]EVV$3\?/:?S Q\^_FN(Q@B3]'U
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M1.9$6FX+MVI_2VA?'^VJL?:7MYD1C4QDUL>H][4YK_\ 99@87AS21J)2.$O
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<**-%%&BBC111HHHT44:**-%%&BBC111HHK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g52141pc_pg001c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52141pc_pg001c.jpg
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M Q$!_\0 I@    0' 0               P0%"@ "!@<("0L! 0$! 0$! 0
M             0,"! 40   % @($" 0-%0$       $#! 4& @< "!$A$A,Q
M83(T%187"3,4-SI!48$B4F,U539VMQ@9P4*#)%1D=-1%9;7%)E9F.(B8.4D:
M"A$!  $"! 4%              $1 B%!81(Q48$R%''!0A-#_]H # ,!  (1
M Q$ /P!S5WI5P9M#)-E'98[<JZ5N(M*+@7*7W"36GF+G!9')V2&0-7)4[4:[
MLM9:L4ZHY!LB CLAM:<%B*S$:F;LD_\ 17?$)"^%1MDS$E1](\/+8WE.>;*?
M]-"@1/%3>2M-*\>V1-V*=/IX/7XQ&_Z+<PGO;?OU<V,^T^K]O<.*>-;JC_HN
MS">]M^_[L9]^/8'C6ZLH,HG?:W+S/7D(L),7C--!%$ZAD\&&S>(9J9NK<([,
MFJ(.[TU*7-M<UM21R:2U""D1I !IT8C.;(MFE.!TMVOW6^A-[9>TB4=L'S2^
MM':AUB4=;.MW06\ZQ]/;6^Z4\:]?IT\K5P8E7&'V:*0[XOW?RD_&"^/R,R#%
M9V]T>KEJKN?OOQE>?TPOQ,WT,Q''3I& S\[L/^>"S'X)<3Y.)/B9O-=W2Z$'
M^@/^CC]38K/Y]/94W>]-ZQVEV3IJ;D@K'5?*;X)$1-(UZ5!ZFS3^00E*)IJ"
MHY0>;73312&L:A  X<1E'&*<W+H?XG,&J0R9K<(;+6IP02A[3*"#8R])%S:=
M0\N--1]9"Y*>0I(TAPCI#%>FLQ@(= 23]U9./'U4>]?'J3:->(M;N8$6&1:1
M_9R4!K'5U3?-7%S7T,,7.Z[G+8=W5L#G+UGBM><TP^8G)V6-7/D+^LJCJY&T
M-[:TVYDF[-6KG B@I()U=>BH $-K#4J?\[0?0!;S9IWGS--O=[0['C/0FG=;
M7)V=[JT\GU,&?Z"G>TO9]R;GY<+%6EB\_E^8V#$R?,$WO=N;ELML%%HX8U)S
M65;*I6]OZ92T)VUU/),3IP/&F@13FZ1 -8&<<6I1K@68V:0N1W<;3WR7P.++
M%#9+[CD9N<LK@SQY:)U9BEOE"Q*WK$844GF"(U&G4#I'AP>@4<[>YA&* ,%U
M7JEV;K6R972VQVXJ_-MEC1QV4N)E6P6G8U!*%0A,IJJU -!M>!7$H2*U69.'
M*H4V3)OD$:=+BB1U(1.F;#+4DHF!:NB@U#5&#Q:ZCW$TXDRFH W84U[6D!T8
MIJ476SV;1JF+M8GQ6Y3/<B7196)UMFK-AEW9Y_)(JZ(%!4B! S-J2A\6IU#7
M56)=*4*PJ( S7I'5,3#HV,4YFLOE7<MFQ*FW]QQ;"& C)B=8$'P@;R%W25J%
M$$2V[J<-QZV6'+41U=->[UC0-7 &G!G^A5R)7FM1=2]O>173O/<R*Q"YK_>B
M49>&8N4OC(G<8S;&W[&6T-A+*V+S:*$[2*\Y2NV!#='J3:JZP$:QP9"9&0'(
M-6Q2$J39RFIYN"\KSW5CF:.7PB.MK"294%1-)MM&A85#I+6%.G:,6D5UU#HX
M->D[WW UW=_9!%\7:T3;G+:DUPV\2RW^=*)E"7EK>DPC4)U)%KURTR$QA3L5
M %)R(B@VD0$=.O4/LN3O'=^]WL>OC%4;SAHF!,V4DA+VURGT3E?6D H"E2>R
M+Y M/66_/6U@-=8L]1=- U:*0  #!-]R\EG,L^1K+[?2/7HMGFRB:&,L:1:E
M+@,GED+F *')8D,15J>O[ZL42],462<9NT])NZ+&L=D,%WW,<&5#EJ^DZN76
M-U+<UV2[4K'YN"TW6EB&();[=B^82$&AXQOO%J5R]Q&AZW&UK5IM_HVPTX.=
MTUKF0[\^5RZ/F_?P]<_*QY6N>)?*)_&/W=QX(MZGY_3YMYRJ^7S[T/!>T>QP
M'M'AS/-N_K?!\[^S<7I\6 &K\(E\W'Y1O/N=</Y-]J]CQ8"4GEU^;D<-7+\)
FPASK[[^IHP%8HO)=)?\ !-\/8/S7R;^Y=PO=O\^>]?M72& __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g52141pc_pg001d.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52141pc_pg001d.jpg
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M Q$!_\0 B0   @,  P$             !@H'" L  P0) 0$  P$!
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'^>!R\:G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g52141pc_pg001e.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52141pc_pg001e.jpg
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M Q$!_\0 W0 !  (" P$! 0            $"!@<#" D$!0H! 0 # 0$! 0$
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M8C C@8C C@8C C@8C C&!2C3DR(C@8TJ&!&(P*6*48BL0P%$1$-8.:047&
M'?'7WVEM"*VGQ-!;TJ&!0\KP =H.71W/ P!2N4! 1 2[0OT X!$1'N.UB\&M
MIZ(HH1H"ZJ7*N3=:J[P*\.=D%U.T=54IHV75U6EQJI1>LPE-.3-4*1,GHN0F
M, 3:;B8@[<3RBP=8ZVP,8AYA:U0\]I#0<_BG(NOEW\/U)4*KH.=W35W)Q(KJ
MQKB1T?.5M<URKDU-R.)-%00@B)*7E9DZ4X1(AA H.<!7 +>I4);"F+D418CS
MG=.:; &M 7Z3AEA[*K^F;09C7GJI699+(M<=<=AE\QNZ#2Z3D== I+<M 7ZD
MEJ6GZ-CW&E-#8>;$R2)0'I$0)VEB2^;)@(ACQRC(#+E!(D69U6,"$!A@0#&"
M&]PZF]&'(Y>^(+A,31C$#1+OOM]!Z&?I7Z34L&+DNU:35^NUZ:B%-3#'=/50
MPHHT]'1CO?\ ;J@+S!$>8"%L6@\8\EJVO;-T!*Z>E$K+<"3*8U0+H,.&EAR&
M=PT1E**52>##2PP6GB&@CTND>C,+FO6;MO56IQJT\ Z[#>T88#S31E:.CHRK
MNO/RUS2ZMSKR7KKE<>>,GK4,5>$"'N^@/1'0]'BL]QUWV0YZ722MC7^Q U#9
MV;TJF2R@%TBF2:/,:GGZZ.HB0*=E:93#3"<$T"*$4PQ#1  NR4SA'4W+*9:)
MFX"7]&.V@>E?'80X62[$J7UV-6:[$<FT%YV%58,-@$>*\Z7@'7R"*& L)#5H
MZ38QZJJ1%6<U22BEI-+Y5*9E/J7@5+&F*1;/Y7+%YI4]/&(8Y8AIC&$"PR&
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M81 1!NC?$V#SI,0AUWT#^C%]D]C%BB\] ?KDYK;T6J..PX)#CAT80]R&:*7
M/==.1F19PEQ083I6IIQ9.[?UY;V8TB6*$BCU)9J>HU%/1HI#08P0E*!,J-%,
M,,VD[Q>Y[8FOUQX/AY]]_3(:WZ?SKYZ+?*^%9=KE6K<RKT6KS!\&M.O/L=BY
M2 ^"6 .Y ,E/8OW9GB@P+7%C2Q54MRZ0FZF31 BRT9_)ZGEL5'&$Y8@0XT%7
M+($.+!VRE$21-HHBTP*]&JKNC!>T7CE21WNO-=R!&@2.O1:G4ZR[\QR&SVC2
M*'LKKP&0AAI*_12W"P+*XTP4P*YLETDY/!BS %DZ@(R1HD".52G-T*L894\&
M&I*!]@@% 3 \0;8SBLM[V)$R49?2O8>Q,O\ N.PX(G-9TJM#(AT@$.OC1>#1
M2^\7:"2T@=-*RZ/7^#N8U3!KA1=*P\:K4_0C GL:MJ?*LAG3DZ*'%,0RP"&4
MP2 Z&<0V@+H =#5WC6'(1JHBLA$--.0'(O/JM\KS0)#$NK59I'@W<B:38(>!
M:2=)YKV4.O$EKHH/H4U7<["+5RN6+:PNU8Z?19/'!3+(BFN)(J]#C@8IP,$&
M&K,6*&V0!TZ'M%6F+]2=(@1!H=5&5<TCO=>6[M3C5.1UZ+4X=:<,.*ZZ\/F.
M#("1D-)IRE8G$NU@=DD>HE@7!M!"456EBH:E]"F7II)G+XCPCICPTA(T."FB
M!I,2& "9KQ9C%+O<OODQ =(%N1O]*%W1<0+Z5ARI5>/-:P]N^(Z_5O:!,)]W
M(^WZ[SHR M6"*,067[*ZK05>CK&0JJUER-'+9=,J9IRM)C,"H)=#"&C0E*CE
M8IHB>!!<!2F%S2_-:R]5Q5HE8 A=+ "?I71'Q-OS'D\6[<:9QC(HT1]^) >=
M=(B/Q"UY\/,:'GBTGII7U57B6P\7(42Y1#LU>6[LREYAB2B)+K73J GA")A,
M.VM7&2P^@.8H;13E$KN1L(-?C5)TFKO/O.$931ZEY,AOM>6[56B52[E;CU&J
M5CWA#(:64-+SU(/H(85^-,*CN7<14N445@&@RV+,I:GD42IKJU'*J6@1I9",
M)T\'T:2%"9)DJ,1VMD!VA[K:NS&:0G1#=) ;I4GTKJJ6(%^)=#<JTOF<Q=A0
MHKT:%WCPB..Q7A\Q]A:#I#TK*998G$E5DE24Y7=Y:;L]04(@)S6]P^R8R14*
M(?\ "HHM7S$!6!TY7@:,7RQ,+WMR1(E8K$8Q(SS2O#F<SF<]KS\WG,>+69E6
M#I/17S2>A@'0!T="[2VYMM1-IZ7@4G0LG-+99".:.JCJ8L9?.9RN/_AII/)L
MI$RF:+HQGOB'$1![@T,=&@2>DKC#K*5F>DSW%B<FL.1K:35*;)O--^J+&]J)
ML'\PWZH^)C>U$V#^8;]4?$QO:B;!_,-^J/B8WM1-@_F&_5'Q,;VHFR?S#?JC
M]K&HHZ,P"_9-I[PL1BG9-YIN86-ZBC$V3<I1#Z2B+^\'?<QM![$.0]BRR4@/
MY4JHNR9_2RK1L&?_ (R2<[<\7_50OA>_NE81C_Y4(_LO?W2O #'!B,SC4>**
MY<KPR88KDJK*2:-+952DT42FA%!)]&3)"^GSN71E\YA*_5BN.(]$6(4# X7M
M]3=Z;8>P95"A3BI5R+,0\6O.- /Y5^F70GV$%4N_!J]Z99,ZQ.0^>\?A/,AE
MWZK <G:NJ.\EQ!7ROW ]R6Y^.-[&^L++.F.L5]1Q'R_V/.-<IO)<05\KU?\
MN2W/QQIWUA99TQUBG$?+_8\XURF\GQ!&G^%VO-6GV);K5R/]NZFMOK"FSICK
M%6XEP"Z9-.-=-Y/B".3"[7;^])+<_9/6;ZPKLZ8ZQ5>*.7VQ)QM%3>4X@EP_
MPO5\Y^GV#;?7HU^WM;3OG"NSICK%5XHY?;$G&T3>4X@KY7*]U_Y#MTY^C_/K
MGZFKOK"JSICK%.)>7JQ9SM"KCB3X@E^G"[7CWCKDEN7OTOUSU[];-]X56=,=
M8JW%'+[8DX;]HJ;RG$$Z?X7J^Y7^P;;ZW _]O=QS3OG"GIETPUBH%Z.7[HDD
MXVBY-Y/B"?E=KS6/[$MS][E_;NMHWWA59TQUBG%'+[8DXVB@<2G$%.TX7:\<
M\=<BMRY^A_[<UM&^\*[.F67^T5;B7 /ID\WUU&\IQ!.R'\+M=[/)["MSL^#V
MXYF^\+&?ATR9\15>)< +'FVNF\GQ SO]EVNW.%WL2W+G:7_MW5K>UM]85=,N
MF/K*OQ+@%8TXUR@XE.()Y<+M=^&16Y^.-7?6%=G3+6*KQ+@%8\WUU(8E.(*=
MY.%VO'.TND5N7.?IU3S4]HWWA59TRUBK<2X!V/.-=<2C$WQ ,&$G*OPM54<A
MHI/5PS2F[6QB^D;>CT(RR<GV8VUJZ-QGM9Z=X4M]N73!O63^E4XCY?6^U)YO
MI?&N>)B4XA#I#C%PN7 Z41#;")([=@+M#] SQX T[ZPJLZ8L^(JO$?+]3_\
M'F[/C5"XE.()=Y>%ZOG[!G^P;<ZG_P#GOW6G?>%?1+IBWM*MQ/R]],GG'KSJ
M!Q*<0/L_[+M?.T?L*W+G\C_;P ]H$ZPKZ)=,=8IQ1R^#^23@_OJI<2?$$^1_
M"[7W]UKDENN__GUI$[PKZ)=,?6587EP".233AGQJP8F>(%AQTY1PMUD*DYS
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MJ8>MO0(](GPU ?:TZ!?6("]K"=X5LIEU?9VJ@O%R\ G1D\V9T_,"Y$F(W,$
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)&1"X\]^R"O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g52141pc_pg001f.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g52141pc_pg001f.jpg
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M Q$!_\0 ]P   00# 0$! 0            8'" D! P4"! H+ 0$   <! 0
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MJQYGFI:5MD$E2WIRRF0 .\D 1OS3O$R)8%SFLZUL:P+V=LO&$?EK*I+KN=&
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M1E'208G4_9Q;LNIKY^W-S%-H"P4U/4NUC*"MRH9K #2!AH_^8Z#,@^+(P_\
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MT%M'7QQCQC7>%D&[;ABTYJQXF/MJ3GVMONWR*SM(+=<KJ<J8OWSGE9NCNP^
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M5+7Z)RH*BMT-GV2$$Y0K?NB<-8Q'.<%(04A!2$%(1K4$=   [1T$==- \],
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M*!Q,)06$  2AVUZ537M3R*.H60M3><%2M@VC';ZD>G;1SAO5XI=(5]8H53]
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MV@\J.;_NJOKAU1\G?UYBK'>G]5AX=W]I7_6:Z:^>=Z[R?7CM7L[_ &T>:_\
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MKQH;DG_$@J/EZN\"H<+P#/F'QGY0;M_ET*I^:/SC3\'1Z\8K]YQ]I5WY+IO
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ME !U'0>T/^6G?CRI(4)&/ I\-!.8  -  ![?(/OB-0D1@F0@$S4#CA^",@D
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MMYW4 -*20H!/5((]:+C=.;?-*Z6MYU^@4BPNLN)="6EI:6VZ)#&6"4"60@R
MVPKOP"8PA$\ARL7=#F'D;C:/&]]RBLHW=(*.W+GUBBZEFSDQFZ*C45.4I#<H
M"D.E4B;O6+=92ML+"% H3([!N$8]_BEJ^YKM5'5T;=134:TFC:2VI)"$IX90
MTI("B%;2H3(5C#>!M6P<Z@FZC^^';U^ND1W[1J3[<@K0*IA2/&-FQE>[HP)W
M*FI2@ E*?0 &JX:ANC;JE,LH3.8R!.&;IGMS;1&6JYV\R6;FM%';6V:,'A\
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M;6@*RK"#F*"=@5T3_DC<6O\ D'K/E]8EW^M=H*RDI:A-/6"E>#RJ)]8FEJH
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ML+6@*!4E)V$CO1O_ %!V<M=:?TN_J-UVWU%914S=3643+Z7*NDIW99'GD)F
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MVF$A*[1<TR#Q&<5R% *3DC*PMS20)MG35I%7!:Z:;>"7C.0_,JV39\Y#D$
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M1W]>?PQ5AO2U_P!UAX=@!Q_I*_NWR>^/E'0:S738RZTO!W21+\!CMGL\H/\
MG2YK993X5%$][0'^E_ U#CH$-<FIAT'_ $!UJ'GK%*I,E:C Z4^M'+^H 11=
MI%6&7SA@'_XTQ&&XQTV">(MJ&FF^F*$/* \T^I]FKX@D:IM1/_3#X!&Y[//_
M #-\IEG$'EJ[+_Z($65>,6 #X6>,/*!%\1B.@\?ZC3#4 \H5B/+OY[OJ]C)[
MRHY#[ 9EVT[XD[D7.8W_ *>*>[U 3>"#B73AR[E;FU ?W7!3B7C6?4A/^)+Z
M=PHT#\<=ZZ<ZWWC=^^B-/ZW^G<B0MI@'YB_A4%$=!#=\Y'7R '?&P]H=HU9Z
ME!.IKYT>9@?B,:JO:3_F7YU@^+^P8\A6$.S>8:6_XY8!\+OUK\!'0=-4M1 0
MX>7LJV4W5<T\HSF$J\$HP33RO_RO9O2D=;A5/@(B8&Z?3_<900:#I^!W&_9V
MZ]5GKI[@#5GL20.9B@-G'</X08T/R4'_ /2.H2K_ *]7]_ *AP_ -^8A&\?_
M )@W;]CXY"J/FD):C _X='KQB?WG/VEWODNF\"HNSK6T?.^&>SMC^R\B8RNN
M*O>U(>\(]A;\]+L8R<CTI5DG*LX9\+-V5BN51)9R@<VJ>I3"!NSC2 ,C.(A^
M$^U=,=AF#VKUBZCED&URIBR>,U&"S=,MUS (D,S5*0Z)"IZ<A=  "Z<*0)GC
M$5+>S;C;9_XD^\Z6W%SBF,K;S59.+;KQG=TW'21[8NIG:\8YCI^-82K-HY0]
M=QS@0$S8PE.8H^CJ/"D1)F)=$/1X2S"6D<8[@<JKPLQ#6GFO<]D[(>.33S%Q
M%R4S9;YVW;1<^:.=$3<MFLKT#*(<Y0$Z>@TB$1'Q;@W=-E#>7XD@8:W(2.WV
MT'V4K*CY&--CYK<#B9=.+..DYN&#E944TTE2-Q%,HI\Y2GTUI$9X2BT#$^+,
M2>'/M)D(#UM+S%F8YC+GO6\;BF4AD)^\KEFUUY.>D5V;1%4%9*XY5<"$13()
M0$Y2Z::C2(12SLFLZ\]D>ZV,SYGK&(0F+?$'E9$<3$C63Z33V@3<\[/+0>+W
MJ IK)P$1D]JJ1Z[50!)--^?IG[!+2)JE!2<-T?I[#0!T$=3#J/']KR!PI$J/
M=(04A$;MWEL3UY;:<SVU;#9=].REBS*<>Q; )EWJB:77,T2*'PCN$TC% /+K
MI5ZT[4-TU[IGW3)M+H)/@C:_(F]6G3W.+3MWO:T-6QFYM%QQ?BH!.7.KH"20
M2=TH@%9=ZP&<,V;%6N,"N7B^(+ FG^2N6.=,B66B2V6,">WYDZJ*16S]U*(F
M*5#41,!.:LNJZ9ZU6RZ^D0$^<NIX<R#F(459A+N'O1U%JC3%WY:\M^9B]:*0
MV+]=6$6X\1*_/":A;X?: )S-AH@E>Z<ML6QW=*04):]PS5S$(>WXF'D)&<3.
MW%X12,:-5%WI#-0(<70'0((=/0>;72M>,-NO.MI8/NA4 G&4C/ SW1PO8Z.Y
MW&[TE!:9^EGZEMMJ2LA#BE!*9*F,LE$'-/ 8Q4A@S-&+MVN><;W[<5U0]HVK
MCV3F4-M^"6\:\CYQ>6(@K'KWU=J8LT6S)<S IRL691*5-,PB;B/'/[I;+A8;
M6[3LH6XZ\D%]W,""G;E3B9X[28[OYE\NM9\B^6%WTK;*"HK[_=6FEWV]J<0M
MA+14%BBINN5+3GEQG3,J4)#"+AWJH)-72@HF=&2:KJ]U3 !,Y%-,YQ;D*/ Q
MUA#E /+K6M1E4X$A0SD@8CI_TQC@)A <?;:S!$U)&;8!,^,3ND<3WHI:R5E"
MU,I9GVR7]B.1NN6O:V,JDM=WM?G8(\=#6<T+W]A=%^OH]%HB6)E(-$O50="<
M4U"K<.(C6TJ"D?H[=64-R#:*5=-F\X"IJ4K#(@&?6&XIW1]#=(:+ONC>7NLM
M+:[;HV-/5ED-0C4;+N=RK7U'*:B2LJ/$;=)R+: S#)CLBZLX"('X<X@43<H?
MOM-1)J'[/NUJ\A*C)0FF?AZ8^=<A@ <9B?0);3%)VY'*EH90N#%4KC=S=J.3
M,:9UAX4-J<M;XM82Y)-"=.UE+SF8QNU3#DCHU=1\U?\ /TPTU'B-;-LU&NA0
M]3UW#-&]1J_6$F9 (F&P9[R)%,?1KE'HF^Z.M%\H-8HH7-'7K33KIU(R_F>I
MT%@*;I&W5*/CN!++C$LTL!@(NO2-SE3Y@!,PD)S ':0_* B37S%,(A6MBG$X
MQ\YCDS=0A3*3@=^!D/P[8IIWIY+L3(T/*6_;TM>%K93Q)E>%.QV^+V^8D+G*
MXDYV/5CWDLT;-.:8@G:!C+D=E4T2,D G[*V3I>AJK?4H<>#;E#44ZAQ\V+22
MDC SZI!PEOCZ$]G31^I-)5S-UNE/05FBK]8W@N^!Z;MEIU,K#B6U*5)IY*NH
MILIZP40G;%P\"J\=P\4O(LR1K]>+CUG[ AP.1B\4:HG<LR#Y2MU1$@#Y@K7#
MH"7U)2K,D*,CN(G' =Q;IVKC4-T;A>I4/N);<.UQ 40%RZ5#'U8K]WMV3 HW
M[M=O&-M=J>Z)#<58S*6N-G% XF/531N]%-%T_3(=9".3$>/$I \M9AI>H5YG
M<*=QPAD4:RE)5A.8V#ICJGLYZAN)TSK6PUM<L6-&DZM;5.MS*UQE*1-24$@*
M<.XR)VQ8OR 83AQ >;M\^HCH #YJPL&4Y##?..22G/@O%/?W179N6LB!B]SF
MS>YX6UVB$U,99N(]R7&QBP._=HI6DX(@65DDTQ4*V*8="@<P$U&LSL-4IRS7
M&G=6>&*9.1)5@#FW#ICK#D[J2XU7)KF!8[C6K50,6-@4].XYU$SJAFX;9,BJ
M6)D"8L6)_&#V^7W@X\ K#)JS93XHCE'$F>Z4;J]1&-2W-RARAQU#LTUT\NFO
MEJ(E/'_0[H@0#@=D02W'#GYOD=J?&!KA6MR9L=U!.R1A4S-8:;4= X1GB\W$
M7:*!!3#W1K*;*;2:$^?)3YRAS/C[(2\6.E.40Y6/:67^V@I47BFN2'AQ29O,
MA.4L]Z?6,(?'<=N2MRW<D^OB7%(3UQ6H@C99!=F7 )UTMW4TJ\55#EC'K,/3
M,F7T!+QJHJ7+&_5,%D(33)5F7,;0,9>M&4:OJ^3UXN]G]%>9LVNEKU+JSEE[
MB@9N$@#](A>P$XSCZKGF,XL+0PD_EHR]W5UVRZ=L[LM^'*)T;F?QQP(20=R"
M <I"."Z"4J@<AP$:\,&U+JZK+PN"Z I*I>*#N WRBELM'RTJ;]J:DMSUM18:
MUM"J5YT &F;6)J;2V3M3O*<1A"%=2.\)!\@1:)NLJQRW4MRME$7#8L==O(,,
M94Y?1(^M8_ B?D"J]-/IYQ!5G:"B$">SQ#B>Z5;]T9.Q1<@'&#PJBB53CS83
M(*59Z8>Z@ XE%1^5OCNXWB-Q-BJVY?=_3-VO8AU<RT7.VZV!:7E)!OW59!I-
MO6G)R1S8K@"^BGJ AQ&I-8]9JH.4=(VVESA]59P!(VXQ;M7U_*74U/5Z7TQ3
MV]FO;I ZQ4+DTVWUDE3*%SFXLB>*MFP0H['-E]/%^7>XH7:\R=<,LX8P7K3O
MB"D<C(/% :/FIW8=V0(R:B!M2>B AQJ0^;6+I2\0MIHT- KECF4D8B4634J.
M7SFLK#YWYBWI&EITKJ"UD4%E"1F2K+UCF5A(XF&TD)3=:LT=IST??*<#,/8.
M(G21!2FE;;]G&Z:$X_BU4PYW;.Y$2B<IR\05[*KFTV)*04%@NM!2DDC!6<X
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M$1$1'F\P>8 [- $:C+&7L8AE,@9XSC/3$>(',&@:>^/EX=@<0I($Q'+(S!C
MIB;34X]NN@::#IYZCW.B(244[0#OEOCT)!$- .(<0XZ /8/9H(4D8B!A&.GP
M'TAU'R_X]:\J3,$#?$,NWIC($T$/2$0 . #Y_/K21!G$4I*</8QLKU'J,#KI
MPX#Y*0CB7+"DN.V[@MY18S8D]"2T*=P0 ,= DHQ78F7*4W QDP7Y@ >T0I"*
MV_"U\-*W/#(Q=E#&5M9+G<FMLEY8N'*;F3GF#6/<1CJX%E5E(M!-J8Q%&[?J
MZ 8>(TB),Q%G^G#2D0CR8X@.@!J/FUT]W0/=TJ$P-L(\ KV\--./'0=0^P/
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M0@I""D(*0@I""D(*0@I""D(*0A+W=[)>IG?MIZE]2=W6[WZ[[MW7N_3'K_\
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((04A!2$?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
